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Insulin sensitivity (SI) in horses is affected by diet, exercise and obesity and has 
been implicated in metabolic disease.  The objectives of this research were to assess 
the impact of BW gain on SI utilizing two diets known to differentially impact 
glucose dynamics, evaluate the contribution of light exercise to overall SI and relate 
changes in SI to BCS to identify the threshold at which SI declines to a level 
consistent with an increased risk of metabolic disease.  Fifteen mature Thoroughbred 
geldings (BW 516 ± 13 kg, BCS 4.3 ± 0.1) were fed to gain 90.8 kg on a diet high in 
fat and fiber (HF, n = 6) starch and sugar (HS, n = 9).  To assess SI, frequently 
sampled i.v. glucose tolerance tests were performed before treatment initiation 
(CFMM), at the start (TXMM) and end (ENDMM) of weight gain and following a 
  
 
period of minimal exercise.  Using the minimal model of glucose dynamics, data 
from each test was used to estimate SI, glucose effectiveness (Sg) and the acute 
insulin response to glucose (AIRg).  Final BW was 608 ± 12 kg and BCS was 7 ± 0.1.  
Diet had no effect on SI, AIRg or glucose effectiveness at CFMM.  Within HF, SI, Sg 
and AIRg were unchanged at CFMM, TXMM and ENDMM.  SI decreased at TXMM 
in HS (P = 0.05) and remained unchanged through ENDMM.  SI in HS was lower 
than HF at TXMM (P = 0.01) and ENDMM (P = 0.07).  At ENDMM, AIRg was 
higher in HS than HF (P = 0.01) and glucose effectiveness was reduced in both diets 
(P < 0.05).  Following the minimal exercise period, SI decreased in HF (P = 0.03).  
These results indicate that diet may be more influential on SI than weight gain in 
mature Thoroughbred geldings.  The higher SI in HF appears to be partially 
dependent on some level of physical activity.  Because a BCS increase of 3 scores 
was not associated with a reduction in SI, the BCS where the perceived risk of 
metabolic disease is increased likely lies above that achieved in this study (BCS 7). 
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conditions, including a d
Christison, 1990), reduced athletic ability (Webb et al., 1989), abnormal estrous cycling 
(Gentry et al., 2002; Fitzgerald et al., 2003), insulin resistance (IR; Hoffman et al., 2003) 
and laminitis (Treiber et al., 2006).  Of th
insidious, appeari
metabolic diseases, such  
As the cornerstone of the hum e, IR has been linked to diabetes and 
cardiovascular disease and is a widely studied metabolic disorder with numerous 
contributing factors.  In th
induced and natur
laminitis, especially in obese ponies (Coffman and Colles, 1983).  Insulin resistance in 
ied using techniques developed in human medicine, 
adapted for use in veterinary medicine and equine research (Hoffman et al., 2003).  An 
understanding of the etiology of IR as it relates to metabolic disease in humans will allow 
for parallels to be drawn to the horse, some of which have already been explored.  The 
pages to follow are meant to both encompass current knowledge in equine nutrition as it 
relates to obesity in the horse and pony and to present original research findings based on 
related hypotheses.    
H ER 1: INTRODUCTION AND OBJECTIVES 
 
 horse and pony has been associated with several negative health 
ecreased ability to thermoregulate in hot weather (Cymbaluk and 
e afore-mentioned issues, IR is the most 
ng in otherwise healthy animals and slowly increasing the risk of 
 as laminitis, in susceptible individuals (Johnson et al., 2002). 
an Metabolic Syndrom
e equid, early observations of hormonal dysregulation during 
ally occurring laminitis led to key experiments which linked IR and 





The objectives of this dissertation are to:  
 
1. Summarize the current knowledge of obesity and IR in the horse in 
such a way that the link between IR and metabolic disease becomes 
apparent. Through a review of previous research in the horse and pony, 
, 
the hypothesis of excessive adiposity as a contributing factor to 
laminitis will be established. 
 
2. Provide background information on insulin sensitivity (SI) drawn from 
human and other research models to lend credence to this field as well 
as establish its general importance.  The depth of information provided 
is meant to cover current knowledge of insulin secretion and action as 
well as highlight the many factors that interact in the complex etiology 
of the human Metabolic Syndrome and its applications to the horse. 
 
3. Describe techniques used for the determination of glucose tolerance
ranging from simple, indirect estimates to sophisticated, complex 
protocols.  Special emphasis will be place on the minimal model of 






4. Present original research findings related to body weight, diet and 
exercise effects on SI in the horse.  Objectives of the research include  
 
a. An evaluation of the effect of controlled weight gain on SI, the satiety 
hormone leptin and two markers of oxidative stress, lipid 
hydroperoxide (LPO) and glutathione in the mature Thoroughbred 
gelding.   
 
b. An estimation of the contribution of dietary energy source to changes 
in SI that may occur prior to and following controlled weight gain 
utilizing two treatment concentrates, one high in starch and sugar and 
the other high in fat and fiber. 
 
c. An appraisal of the impact of exercise on SI through the cessation of 






CHAPTER 2: LITERATURE REVIEW 
 
inal floor (Bianchi, 1989).  Equine body fat has been 
measured using visual appraisal of the horse’s body condition, ultrasound, total body 
water, cadaver dissection and others as discussed in a review by Kearns et al. (2002).  
ody fat composition in the horse are a 
andardized body condition score (BCS) system (Henneke et al., 1983; Carroll and 
Huntington, 1988) and the use of ultrasound (Westervelt et al. 1976; Kane et al., 1987).  
The most widely used BCS system was developed by Henneke et al. (1983) and is a 
subjective measure of body fat accumulation determined via observation and palpation of 
fat deposition in specific areas on the horse (neck, withers, loin, tailhead, shoulder and 
ribs).  The degree of body fat cover over the skeletal structure is used to create a 
numerical score that ranges from 1 to 9, with half scores possible. The Henneke BCS 
system was developed to study the effects of BCS on mare reproductive efficiency and 
was patterned after a similar system used in cattle (Henneke et al., 1983).  Although it has 
 
PART I: EQUINE BODY COMPOSITION 
Equine obesity 
Horses deposit s.c. fat in specific areas of the body, including the crest of the neck, on 
the withers, behind the shoulder, over the ribs, along the loin and around the tailhead 
(Henneke et al., 1983). Additionally, fat is deposited around the internal organs and 
viscera, with additional fat depots located in the perineum, supraorbital fossa, orbit of the 
eye, mediastinum, subepicardium, mesentery, omentum, around the kidney, in the 
epidural space and on the abdom





been recommended for use in all types of equids, including both light horse and draft 
breeds (Potter et al., 1987), as well as ponies (Freestone et al., 1992), the original system 
was developed in pre-parturient and lactating Quarter Horse mares (Henneke et al., 
19
orse.  
 be deposited between the thighs 
(gaskins; Henneke et al., 1983).  The distinction between BCS 8 and BCS 9 (‘extremely 
83).  While the Henneke BCS system is very useful for tracking body fat changes in an 
individual animal, its limitations are recognized when differences in gender, age, breed, 
and conformation among horses are considered.  Additionally, users of a BCS system 
must be properly trained on the usage of the system in order to attain proper repeatability, 
reproducibility and predictability (Burkholder, 2002), which may limit the ability of a 
BCS to be compared across studies. Using the Henneke BCS system, it is generally 
recommended that horses be maintained at a BCS of 4.5-6, depending on the 
physiological status of the h
The use of the term ‘obesity’ has only recently begun to be used in published equine 
literature (Hoffman et al., 2003), with ambiguous terms such as ‘fat’ or ‘well-
conditioned’ pervasive in the past literature.  Such terms have always relied heavily on a 
visual component, as the ‘fat’ ponies or horses sometimes are found to weigh less than 
the ‘normal’ individuals (Jeffcott et al., 1986).  It has generally been accepted, however, 
that any horse or pony with a BCS above 7 is most definitely ‘fat’ and may even be 
‘obese.’  In the Henneke system, a BCS of 7 is defined as ‘fleshy’ with a noticeable 
filling of fat between the ribs, along the withers, behind the shoulder and along the neck.  
A BCS of 8 is considered ‘fat,’ with a visible crease down the back, the neck and 
shoulder are flush with the body due to fat filling the area behind the shoulder, the ribs 







fat’) lies in the bulging of the fat in the six areas, as well as fat accu tion between the 
inner thi to t s  r
While a true definition of equine obesity has not been presented in the literature, 
si  
 and is measured using the body mass index (BMI, weight (kg)/height (m²); NIH, 
8).  aus r t t ex in the horse, the 
gn  of ‘obese’ in the horse is only amb  defined using the Henneke BCS 
em  the subsequently re-defined BCS offman et al. (2003).  
il a tive system for estimating th  horses is developed, 
use of the term ‘obese’ may be misleading, in that the current Henneke BCS system 
ws f sig al interpretation fo ch re, resulting in a 
 broad definition of the term. 
racterization of ine body ti
he u f B v   obj rement of equine 
y fat en li d isse rvelt et a 976; 
e et al., 1987).  Ultrasonic measurements of adipose tissue depth on the r  and 
r the tailhead have been used to estimate body fat composition, with increasing fat 
th correlated with increasing BCS (Freestone et al., 1992; Freestone et al., 1992b; 
ell et al., 20 Webb et al., 1989 n 2001). Variati  t ody 
sing ultraso  can occur due to at in scan site location, e to 
r erro  an l conformation di n   Fat depth is te  and 
mula





















ty in the human ‘refers specifically to having an abnormally high proportion of body 














































































site locations and prediction equations deve (1987) are the most 
widely used in the litera
ody composition studies on horses using carcass dissection, total body water 
 1.12 to 34.6 % 
and BCS (Table 1a, b).  Of note, mature 
es se  most body as comp  to their yo r counterparts and 
ore lean 
 horses developed for power, such as Perch s (Julian, 1956), or even the hardy 
dipose tissue is now characterized as a dynamic endocrine organ, producing 
one ting factors to 
an metabolic diseases, including atherosclerosis, hypertension, IR and type II 
ettor et al., 2005).  A distincti  mu de, however, between s.c. and 
eral adip  tissue, which contribute differently 
d esente nd 
eri
easured in the live individ using computed tomography or ma  
agery (Wajchenberg, 2000).  Such measurements have not b d  
ailable carcass data 
s with rostral progression (Westervelt et al., 1976, Kane et al., 1987).  The scan 
loped by Kane et al. 
ture. 
B
methods and ultrasound have shown that body
in horses of
mar
males (Fitzgerald and McManus, 2000; Lehnhard
speed or endurance or both, such as Thoroughbred
than










horse to date and the av
collection sites when determ
 fat percentages range from
 various breed, physiological state 
em to carry the fat ared
 et al., 2004) and horses developed for 
s and Arabians, seem to be m
unge
eron








 of omental, m ric a
gn
 in
tone at masses surrounding the intestines and kidney and can only be 
ual 
does not differentiate between adipose tissue 
etic
 theeen use




Ta  1 erce at, y co ion s e a rel nt ysi gi nf
 




ble a.  P
udy 
nt f bod ndit cor nd eva  ph olo cal i ormation of horses and ponies, 1956 - 1979 




Bod  fat (
Ju e 1 a (4) Mature - 865.75  lian t al., 956  Percheron M - 24.5
 Tho h  4  
(2 M e  
 Ara  ( 3
 Am 5  
R et 1  , 81 - 
b,c uns i horse 8) - 8
 uns i o 5 - - e   
 - - o e ed 3
  - - )  
W & aver, 1979 b 
uns i o 2




K t 1 ,c - 2 7 10.1-24 
roug bred (2) M, G Mature - - 72 14.1
 Quarterhorse ) M atur  - - 386 7.55
bian 1) S  Mature - - 46 8.6 
. Saddlebred (1) M Mature - - 57 24.7
Shetland pony (11) S, G M mo-8y - - 7 – 19 
pecif ed (  - - - 336-559 15.8  
pecif ed p ny (1 )  Ad libitum f d (8) - 150.6 6.40
Shetland pony (11)  N n-ex rcis  (6) - 167.8 15.0  
 Exercised (5 - 139.9 8.96
pecif ed p ny (1 ) 
roug bred (5) 




unspecified horse (6)  1 – 26 - - 81-4 4 
obb  al., 972b
Westervelt et al., 1976
ebb  We
ane e al., 987b
aT
bCD = carcass dissection  
cU u o
dSex, M = mare, S = stallion, G = gelding 
 
BW = total body water 




Table 1 Per t f bo co io ore and re nt ysi gi inf
 
Study B  ( x A P ol a e BW Body fat (%) 
b.  cen at, dy ndit n sc
reed
leva  ph olo cal ormation of horses and ponies, 1984 - 2004 
Se d ge hysi ogic l stat (n) BCS  (kg) n) 
Hennek al 8 Q er se - Pre-foaling 6.1 2 13.8 e et ., 19 4c uart hor (32) M (32) 5 2.8 
   Post-foaling  3 16.25 
   Post-foaling  9 11.4 
Gunn, 1  Thoroughbred  - .6 0 1.12 
 O  (16)  - 2.11 
c Q erhorse (1 - 65d gestation  1
  - ge io  1 14.2 
Thoroughbred cross (23) > N r n
  2 N r n
c Standardbred (14) M, S 3. 3. r
c Various breeds (12) L  522 9
    9 31.3 
Lehnhar a 00 Quarter Horse (31) 4 2
  > O ki  ( 0 14.2 
   2
 (16) 7.6 5 2.5 
 (16) 3.6 4 0 
(21) -  0 -49
   3 535 
2) M 6.2 554.4 0.6 
M 215d stat n 6.9 6 9.2 
M 10 on-p egna t - 470 - 540 12 - 15.5 
 -5 on-p egna t - 419 - 459 7 - 11 
1 – 5 Elite raceho ses - 432 - 444 7.4 - 9.9 
M 16-20 ean 4.4 .15 
 Obese 8.8 5 4 
M -8 Young - 512.7 0.5 
M 20 ld, s nny 5) - 5 7.8 
 Old, fat (3) - 563.1 6.6 
986b
ther
Powell et al., 1989  uart
Fitzgerald and McManus, 2000c,e 
Kearns et al., 2002  
Powell et al., 2002  
d et l., 2 4c 
aTBW
bCD = carcass dissection 
cUS = u o
d
eestimat o ut ’ h
 = total body water 
 
ltras und 
Sex, M = mare, S = stallion, G = gelding 
ed fr m a hors grap  
Subcutaneous adipose tissue is found under the skin and distributed throughout the 
body, quantified in humans using techniques such as waist-to-hip ratio and skinfold 
thickness (Wajchenberg, 2000) and body condition scoring in horses (Henneke et al., 
1983).  In humans, both s.c. and visceral fat are metabolically active, producing both 
hormones and inflammatory mediators that are strong contributors to the onset of 
metabolic disease.   However, it is the relative proportion of visceral fat which determines 
a person’s risk for development of abnormal glucose and insulin regulation and 
ultimately type II diabetes (Wajchenberg, 2000; Kahn, 2003).  Indeed was found that 
humans with greater intra-abdominal fat were more insulin resistant than those with 
increased s.c. fat, even if one group were more lean than the other (Kahn, 2003).  As with 
humans and other mammals, it is possible that individual variations in visceral and s.c. fat 
deposition may partially explain the differences in susceptibility to metabolic disease 
between an
BW and BCS and represent the data as a continuum of BW and BCS in order to correlate 
d within equine breeds.  The metabolically active factors secreted from 
adipose tissue are numerous and a full discussion is beyond the scope of this review (see 
Wajchenberg, 2000).  At this time in the horse, the factors of interest in the development 
of IR include leptin, adiponectin, oxidative stress and cytokines such as tumor necrosis 
factor-α (TNF-α), all of which will be discussed in future sections. 
 
Weight manipulation in the adult horse 
 
A standardized protocol for manipulating horse BW for research purposes does not 




the variable of interest to weight or adiposity.  In the studies which have manipulated BW 
to attain a certain BCS, the resulting groups of horses are usually polarized into high or 
low
tocol and may require a more concentrated source of 
cal
 loss was 1.6 kg/d and the mares dropped one BCS every 16 d.  A slightly 
slower weight loss strategy was used by Gentry et al. (2002), who limit-fed ‘light horse’ 
mares on Alicia bermudagrass and winter ryegrass (2 h/d) until four body condition 
 BCS groups, depending on the objective of the study.  Unfortunately, the procedures 
used to encourage either weight loss or weight gain in past studies have usually been 
omitted.  In addition, those studies which specifically report the techniques used to 
manipulate BW often utilize mixed breeds and sexes, omitting the breed type but 
specifying only ‘light-breed,’ draft or pony in many cases.  However, anecdotal evidence 
exists for differences in body type, metabolism and feed efficiency within the light-horse 
breeds which can have a profound effect on the success of a weight manipulation 
protocol.  For example, Thoroughbred horses are traditionally known for having 
difficulty in maintaining BW and exhibit a well-defined bone structure visible under a 
typically lean physique.  It is likely that this breed will respond faster to a weight loss 
protocol than a weight gain pro
ories to encourage weight gain as compared to a Quarter Horse or Arabian, known for 
a more rapid weight gain response. 
Weight loss 
Weight loss.  Few studies have directly examined the effect of caloric intake on weight 
loss or weight gain.  Powell et al., (2002) fed timothy hay to six mares (16 – 20 years old) 





scores we BCS was 
nt than that of the draft horse, as might 
the
 gain could be achieved when horses were 
offered up to 20 Mcal/d above their daily DE requirements, taking 80 d for one BCS gain.  
Additionally, it was calculated that and intake of 40 Mcal/kg above maintenance would 
re lost (BCS 7 to 3).  The resulting weight loss was 1.1 kg/d and one 
lost every 23 d. 
Weight gain 
Weight gain.  Within the new National Research Council Nutrient Requirements of the 
Horse (NRC, 2007), the DE recommendations for maintenance have been adjusted and 
expanded to account for draft horses, ponies and those horses with greater or lesser 
requirements.  Similarly, it should be expected that the DE required for gain in the adult 
horse should vary with breed and type and that the recommendations made by Lawrence 
(2000) may not be adequate for all horses.  Indeed, it is likely that the DE requirement for 
weight gain in the Thoroughbred would be differe
 rapidity at which weight is gained and the ease of maintaining the achieved BW.  
Heusner et al. (1993) fed horses of mixed sex (breed not given) 44 Mcal/d, 
corresponding to approximately 27 Mcal/d above maintenance for the 500 kg horse.  
Using this strategy, the horses gained 1 kg per day and increased their BCS by one unit 
every 20 d.  A slightly lesser intake was found by Martin-Rosset and Vermorel (1991), 
who calculated 18 Mcal above maintenance was required per kg of gain.  In draft horses, 
a gain of 1 kg/d required 16 – 21 Mcal above maintenance (Potter et al., 1987).  The 
results of these three studies were used to outline recommendations for weight gain in the 
adult horse within the NRC (1989; 2007).  However, research in Thoroughbreds (Quinn 




have been required to achieve one kg of gain per day, an intake which was not achieved 
by any horse.   
In addition to having a slower rate of gain, the weight gain associated with a one-unit 
increase in BCS in the Thoroughbred does not appear to be the same as the studies cited 
by the NRC.  One unit of BCS is reported to correspond to 20 – 25 kg of BW in horses of 
mixed breed and sex (Heusner et al., 1993; Powell et al., 2002; Gentry et al., 2002) but 
has been found to be approximately 32 kg in the Thoroughbred (Quinn et al., 2007).  A 
likely explanation for the breed-specific difference may be the body conformation of the 
Thoroughbred as compared to other light-horse breeds, such as the Quarter Horse.  It may 
be that more fat or muscle or both is required to fill out the six BCS areas to the level 
defined by the Henneke BCS system, and in fact Suagee (unpublished data, 2007) found 
that the Henneke system did not accurately describe fat accretion in the neck, withers and 
loin in Thoroughbred geldings.   
son, 2002), it may be similarly effective in inducing a state of 
metabolic dysfunction.  Within the pony, IR and elevated blood triglycerides are risk 
factors for metabolic disease that have been implicated in the pathogenesis of pasture-
associated laminitis (Treiber et al., 2006) and may similarly be involved in the obese 
Thoroughbred. 
Obesity in the Thoroughbred has been reported in the literature (Hoffman et al., 2003), 





PART II: INSULIN ACTION AND CAUSES OF RESISTANCE 
 
Before describing the complex interplay between hormones and inflammatory factors 
which may be involved in the pathogenesis of IR, the term must be adequately defined.  
Insulin resistance is defined as the impaired response of insulin-sensitive cells in the 
peripheral tissue, whereby the normal level of insulin secretion in response to glucose is 
not enough to encourage adequate glucose disposal into the peripheral tissues (Wilcox, 
2005).  Insulin resistance in peripheral tissues can be partitioned into two components, 
‘insulin sensitivity (SI)’ and ‘insulin effectiveness’ (Kahn, 1979; Kronfeld et al., 2005), 
which a eably in the literature.   re used interchang
Insulin sensitivity refers to the cellular actions following insulin arrival at the target 
tissue, most prominently the binding of insulin to its receptor and initiation of the intra-
cellular signal transduction cascade.  Glucose transport and metabolism within the cell 
are affected by insulin effectiveness and IR occurs when there is a reduction in SI, insulin 
effectiveness or both.  As both problems are usually occurring simultaneously, SI has 
become the preferred all-encompassing term to describe insulin’s effect within the 
peripheral tissues, with a reduction in SI leading to IR.  Indeed, known causes of IR in the 
peripheral tissue include impairments in receptor function and the subsequent signal 
transduction cascade and reduced intra-cellular insulin-dependent glucose transporter 










Release.  The protein hormone insulin is released from the β-cells of the Islets of 
Langerhans within the pancreas (Figure 1), in response to blood glucose, and to a lesser 
extent fat and protein.  Glucose is taken up into the β-cells by the glucose transporter-2 
(GLUT-2), one of a series of transport proteins involved in glucose metabolism in various 
tissue types (Ren et al., 2007).  Once inside the β-cell, glucose is metabolized, 
culminating in ATP production, the closure of sodium-potassium-ATPase channels and 
the generation of a membrane-depolarizing charge.  Following membrane depolarization, 
an influx of extra-cellular calcium leads to exocytosis of insulin secretory granules (Ren 
et al., 2007).  Two distinct pools of secretory granules are found within the β-ce nd 
are each responsible for the characteristic insulin secretory response, which occurs o 
phases.  A small pool of secretory granules remains primed for quick release and is 
responsible for the first phase of the insulin response.  The second pool is made up of 
reserved secretory granules and is released more slowly, creating the second phase of the 
insulin response.   
The first-phase insulin response occurs during the first ten minutes following glucose 
administration and the second phase occurs as the first phase diminishes and may or may 
not be visible during blood testing (Wilcox, 2005).  During meal feeding, this first 
response occurs before glucose is detected within the bloodstream and is driven by the 
central nervous system (Storlien et al., 2004).  This response, known as the cephalic 
phase, is believed to occur in order to initiate rapid inhibition of hepatic glucose output 






lin, reaching its highest value 
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Following binding of insulin to its receptor, the insulin-receptor substrate-1 (IRS-1) is 
activated, initiating the signal transduction cascade, culminating in the movement of 
(Storlien et al., 2004).   Such a phenomenon is assumed to occur in the horse, as the 
insulin response to glucose administration or feed is not dissimilar to other animal models 
(Giraudet et al., 1994).  Following intravenous glucose administration, horses fed a diet 
of ad libitum hay demonstrated a rapid increase in insu
hin 5 minutes, followed by a plateau that lasted for the duration of the 30 min study 
(Giraudet et al., 1994).  While glucose values began to decline almost immediately, 
baseline was not reached within 30 min.  Garcia and Beech (1986) observed a return to 
baseline of 60 min for glucose and 180 min for insulin following intravenous glucose 
dosing.   
Arrival and action 
Arrival and action.  Insulin is released into the portal vein and, after passing through the 
liver, makes its way into the interstitial space by crossing the capillary-endothelial barrier
(Bergman, 1997).  The interstitial fluid is in intimate contact with cells of the target tissue 
(adipose, liver, muscle) and it is from this location that insulin has its action.  Impaired 
movement of insulin from the pancreas to the target tissue (impaired trans-capillary 
movement) was at one time believed to be the primary defect underlying IR (Yang et al., 
1989).   However, lymph insulin, known to be reflective of the insulin concentration 
within the interstitial space (Bergman et al., 1990), circulates in proportion to body size, 
with obese individuals having greater lymph insulin than lean individuals (Castillo et al., 
1994).  Additionally, insulin actually arrives at the interstitial space faster under IR 







































































GLUT-4, the insulin-sensitive glucose transporter, to the cell surface (Figure 2; Chang et 
al., 2004).  The level of whole-body insulin-stimulated glucose uptake is highly 
correlated with GLUT-4 activity (Koranyi et al., 1991) and equine tissues have been 





g es as well as suppress unnecessary endogenous 
hepatic production (Ader, 1997).  Indeed, in diabetic individuals with insufficient SI, 




During fasting and at basal glucose levels, euglycemia is maintained via the actions of
ary glucose transporter involved in glucose transport into the brain and 
entral nervous system, as well as basal glucose uptake in peripheral tissues (Wilcox,
005).  The actions of GLUT-1 are controlled only by glucose and work to enhance 
lucose utilization within those tissu
-stimulated glucose dispo
brain, CNS and peripheral tissues (Ader, 1997).  Additionally, over-expression of GLUT-
1 in cell culture results in enhanced glucose uptake under hyperglycemic conditions 
(Heilig et al., 1995).  The effects of glucose at euglycemia are almost hormone-like and 
have been termed ‘glucose effectiveness (Sg).’  While almost 70% of Sg is devoted to
glucose uptake, the remainder is committed to the suppression of hepatic glucose
production (Ader et al., 1997).  Although Sg is the primary vector for glucose disposal at 
euglycemia, it is only responsible for approximately 80% of the total uptake during that 
time due to the reduced yet still present actions of insulin (Kahn et al., 1994).  The action 
of Sg is not limited to euglycemia, however, in that following a meal or glucose infusion, 
the lull between glucose arrival at the pancreas and insulin arrival at the peripheral tissue 


















Figure 2.  t lo on following insulin binding and activation of the signal transduction cascade. 
 













The ultimate source of insulin resistance may be due to a reduction in the cellular 
sponse to an oth e adequate concentration of insulin or a need for increased insulin 
ulate an adequate cellular response (Kahn, 1978; Kronfeld et al., 2005b).  
When presented graphically (Figure 3), a reduction in SI requires that a greater 
concentration of insulin be released to achieve the maximal biological response.  A 
hange in insulin effectiveness occurs when the biological response to a normal 
oncentration of hormone is reduced.  
Impaired insulin sensitivity 
paired insulin sensitivity.  Insulin sensitivity refers specifically to the ability of the 
sulin receptor to stimulate glucose transport into the cell (Kronfeld et al., 2005).  The 
insulin receptor is a dimer, consisting of two α subunits and two β subunits, the latter of 
which spans the plasma membrane (Figure 4).  Normal insulin binding at the extra-
cellular α subunit initiates a series of biochemical reactions, including auto-
hosphorylation of the β subunit, followed by the activation of intrinsic tyrosine kinase 
ctivity and the activation of the IRS-1 (Youngren, 2007).  The IRS-1 then initiates the 
st of the signal transduction cascade, culminating in GLUT-1 translocation to the cell 
surface.  When SI is reduced, the ability of the receptor to auto-phosphorylate following 
insulin binding is reduced, as is the ensuing tyrosine kinase phosphorylation (Youngren, 
2007).  Without the ability to activate the IRS-1, activation of the downstream signal 


































Figure 3.  Insulin sensitivity and insulin effectiveness.  Decreased SI (a) resulting 
from a shift in the curve to the right, increasing the amount of hormone released to 
encourage a half-maximal response (K ).  Decreased insulin effectiveness (b) 
resulting from a decrease in the upper asymptote and reduced maximal physiological 







igure 4. Insulin receptor.  Following insulin binding at the α-subunit of the insulin 
equent activation of the IRS-1 and initiation 







Downstream signal transduction cascade 
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receptor, autophosphorylation of the β-subunits and activation of intrinsic tyrosine kinase 
activity leads to the phosphorylation and subs
to 
Impaired insulin effectiveness 
Impaired insulin effectiveness.  The effectiveness of insulin ultimately depends on the 
completion of glycogen formation, resulting from successful GLUT-4 glucose uptake and 
activation of the cellular metabolic processes such as hexokinase, required for the 
conversion of glucose-6-phosphate to UDP-glucose (Figure 5; Petersen and Schulman, 
2006).  Excessive FFA and hyperinsulinemia are two important causes of impaired 
insulin effectiveness (Ye, 2007) and have been implicated in the inhibition of both 
GLUT-4 and hexokinase activity in human obesity and diabetes (Petersen and Schulman, 
2006).  Free fatty acids are also associated with a rise in protein kinase C (PKC), which 
phosphorylates the IRS-1 at a serine residue, resulting in inhibition of its actions (Yu et 
al.
reased insulin secretion, eventually resulting in hyperinsulinemia, which in 
itself can cause IR (Polonsky et al., 1988; Marangou et al., 1986). 
the cell surface and unsuccessful glucose uptake (Wilcox, 2005; Petersen and 
Schulman, 2006). 
, 2002). 
The role of the β-cell 
The role of the Β-cell.  The full pathogenesis of IR is not entirely related to functional 
impairments in the peripheral tissues.  Once IR has been diagnosed, it is usually found 
that there is some level of β-cell dysfunction already occurring, although it is usually 
unclear as to whether the IR was caused by the dysfunction or the dysfunction caused the 
IR (Kahn, 2003).   For example, the pancreas can compensate for IR by increasing the 





























Figure 5.  Glucose effectiveness.  Glucose metabolism within the peripheral tissue.  







The ability of the β-cell to adjust the level of insulin secretion to the degree of SI is an 
important concept underlying the ultimate diagnosis of IR.  The relationship between SI 
an
e test (OGTT, IVGTT; Expert Committee, 2003).  During an OGTT or IVGTT, 
ev
The role of the central nervous system 
d insulin secretion in response to glucose is hyperbolic (Flanagan et al., 2000) and is 
described as the product of the two, for any given degree of glucose tolerance (Kahn, 
2003).  Because of this relationship, a change in SI is balanced by a comparative, 
reciprocal change in β-cell function (Kahn et al., 2001).  Such a compensatory 
mechanism leads to the achievement and maintenance of euglycemia, at least for a period 
of time.  Compensation is facilitated by both hyperinsulinemia and increased glucose-
stimulated glucose disposal via enhanced GLUT-1 activity (Flanagan et al., 2000) 
however the exact mechanism by which the β-cell senses a need for increased insulin 
secretion is yet unknown (Ahren and Pacini, 2005).  Candidate theories include 
hyperglycemia and high circulating FFA levels, as both stimulate insulin secretion.   
While the compensatory mechanisms are functioning, an individual can maintain his 
resting blood glucose within the healthy range, only showing evidence of abnormal 
glucose dynamics when subjected to a clinical test, such as an oral or intravenous glucose 
toleranc
idence of impaired glucose tolerance is exhibited by over-secretion of insulin and 
slower glucose disposal in response to a glucose bolus.  The underlying cause of the 
impairment, such as abnormal β-cell function, can be identified using additional tests, 
such as a euglycemic-hyperinsulinemic clamp (EHC) or frequently-sampled IVGTT 





The role of the central nervous system.  While insulin is primarily considered an 
anabolic hormone within the peripheral tissue, the actions of insulin within the brain are 
co
, resulting in a decrease in food intake (Schwartz et al., 2000).  Lower levels of 
NPY have recently been found in the hypothalamus of overweight and obese horses (Buff 
et al., 2007).  
Leptin is produced in by the brain, heart, placenta and s.c. adipocytes and is released 
in proportion to the level of body fat in many species, including horses (Buff et al., 2002; 
Gentry et al., 2002; Cartmill et al., 2003; Kearns et al., 2005; Frank et al., 2006).  In 
addition to its effects within the hypothalamus, leptin stimulates glucose metabolism in 
the peripheral tissue by enhancing cellular uptake and increasing glucose and lipid 
oxidation, thus reducing the amount of glucose and lipid that can be stored as fat (Arch, 
2005).  Leptin has also been implicated in IR.  The binding of leptin to receptors on the β-
cell results in suppression of insulin mRNA expression, interference with secretory 
unter-regulatory.  Insulin is a long-term signal of energy balance, circulating in 
proportion to the level of body fat (Schwartz et al., 2000).  In the normal individual, as 
adiposity increases, the concomitant increase in insulin leads to activation of neural 
pathways involved in the control of food intake, ultimately resulting in a decrease in 
intake and weight loss (Schwartz et al., 2000).  These neural pathways are also regulated 
by the cytokine hormone leptin, an additional long-term indicator of energy balance.  
Both insulin and leptin cross the blood-brain barrier and, in times of excessive adiposity, 
suppress the activity of two hypothalamic neuropeptides, neuropeptide Y (NPY) and 





granule exocytosis and ultimately IR through leptin-stimulated fatty acid oxidation 
(Ceddia, 2005; Zhao, 2006). 
During obesity, however, the high circulating leptin levels are not associated with a 
reduction in food intake or BW, a condition which has been termed ‘leptin resistance 
(Halaas et al., 1997).’  While the ultimate cause of leptin resistance is not yet fully 
understood, a likely mechanism within the hypothalamus is the activation of negative 
feedback systems in response to excessive leptin.  Such systems include impaired 
transport of leptin across the blood-brain barrier, alterations in post-receptor signal 
transduction within the hypothalamus and an increase in the negative regulators of leptin 
signaling (e.g. suppressor of cytokine signaling-3, SOCS3; Ceddia, 2005).  Similar 
mechanisms have been proposed for insulin as well, as reduced insulin transport into the 
CNS was associated with high fat feeding in dogs (Kaiyala et al., 2000).  In the horse, 
recent evaluation of hypothalamic leptin receptor expression has shown an increase in 
leptin receptor concentration with obesity, hypothesized to be a compensatory 
mechan ct reduced sensitivity with increased receptor number (Buff et al., ism to countera
2007). 
Within the peripheral tissue, resistance to leptin, hypothesized to be caused by 
increased SOCS3 activity, can lead to hyperinsulinemia (Zhao et al., 2006).  
Hyperinsulinemia may contribute to leptin resistance as both rats and cultured rat 
adipocytes show an increase in leptin secretion or mRNA expression following insulin 
injection (Saladin et al., 1995; Mueller et al., 1998).  Activity of SOCS3 has also been 




stands to reason that chronically elevated insulin would lead to chronically elevated 
leptin, and vice versa, with neither hormone able to carry out is appropriate action. 
Leptin resistance has been observed in the obese horse and the causative mechanisms, 
while unknown, are likely to be similar to those previously described.  Cartmill et al. 
(2003) divided horses of BCS 7.5-8.6 into two distinct groups, those with ‘high’ 
circulating leptin levels (14.1 ng/mL) and those with ‘low’ circulating leptin levels (2.8 
ng/mL).  The combination of high BCS and high leptin levels were taken to indicate 
leptin resistance.  Additionally, the horses in the high leptin group had a greater insulin 
response to glucose infusion, indicating some level of IR was occurring in these animals 
(C
Adiponectin 
Adiponectin.  The insulin-sensitizing hormone adiponectin is secreted from visceral fat 
tissue in proportion to the level of SI in an individual (Zhao et al., 2006).  As SI is 
reduced in the obese, it is not surprising that adiponectin levels are negatively correlated 
to s.c. fat levels in many species including horses (Vettor, et al., 2005; Kearns et al., 
20
artmill et al., 2003).  An additional requirement for the diagnosis of leptin resistance 
may also be an increased number of leptin receptors in the hypothalamus (Buff et al., 
2007).   
05).  Adiponectin enhances SI and is believed to have a protective effect on the β-cells 
(Zhao et al., 2006).  In addition to its ability to improve SI, adiponectin is negatively 
correlated with tumor-necrosis factor-α (TNF-α), an inflammatory cytokine involved in 







ody fat and negatively correlated to SI, linking adiposity with IR 
and inflammation in the equid (Vick et al., 2007).     
Oxidative stress 
Oxidative stress.  The mitochondrial electron transport chain (ETC) is required for ATP 
ge
F-α.  Obesity in human and experimental animal models, such as rodents, is regarded 
as a state of chronic, low-grade inflammation (Elenkov, 2005).  Cytokines, mediators of 
the immune system, are involved in the immune response against invading pathogens, 
such as during tissue trauma, sepsis, or a bacterial infection.  However, some level of 
cytokine production occurs in healthy individuals, originating from adipose tissue.  As 
adiposity increases, so does the production of cytokines (Elenkov, 2005).  In response to 
a high fat diet, TNF-α has been shown to induce SI by interfering with insulin signaling 
via serine phosphorylation of the insulin receptor and IRS-1 within the hypothalamus and 
peripheral tissue (Souza et al., 2005; Schulman, 2000).  Additionally, TNF-α reduces 
tyrosine phosphorylation of the insulin receptor, reduces GLUT-4 mRNA expression and 
instigates lipolysis by stimulating hormone-sensitive lipase and reducing lipoprotein 
lipase in the peripheral tissues (Coppack, 2001).  In the horse, TNF-α is positively 
correlated to percent b
neration and relies on the transfer of electrons from a donor (NADH or FADH2) to an 
end recipient (O2) through a series of oxidation-reduction reactions.  Leakage of the 
electrons from the ETC results in premature interaction of the electrons with O2 and 
instead of forming H2O, O2-· (superoxide) is formed (Clarkson and Thompson, 2001).  
Under normal conditions, the enzyme superoxide-dismutase (SOD) converts the 
superoxide to hydrogen peroxide (H2O2), which is further converted to H2O and singlet 




superoxide can overwhelm these regulatory enzymes and H2O2 will be instead converted 
into the hydroxyl radical, a highly reactive molecule (Droge, 2002).  In small amounts 
these reactive oxygen species (ROS) can be used for cellular processes such as signal 
tra
et al., 2005) and treatment with antioxidants can offset the 
de
nsduction and smooth muscle relaxation but in large amounts can be toxic.  Excessive 
ROS can damage DNA and lipid membranes, reducing the fluidity of the cellular 
membranes and inactivating membrane-bound receptors and enzymes (Clarkson and 
Thompson, 2001).  Within cell membranes, the polyunsaturated fatty acids are prime 
targets for ROS and can themselves be converted into lipid hydroperoxides (LPO), which 
initiate further damage to the membrane as well as DNA.  
Increased oxidative stress occurs in obesity and type II diabetes in humans.  Excessive 
glucose uptake and metabolism increases the activity of the ETC, resulting in an increase 
in the production of superoxide and further ROS which can damage the functionality of 
the β-cell (Droge, 2002).  Additionally, H2O2 can enhance insulin receptor 
autophosphorylation and at very high concentrations can actually stimulate receptor 
autophosphorylation and initiate the signal transduction cascade in the absence of insulin 
(Droge, 2002).  However, prolonged exposure to high or medium H2O2 levels can 
actually decrease insulin receptor signaling (Droge, 2002).     
In horses, increased oxidative stress is most often associated with exercise (Mills et 
al., 1996; de Moffarts 
trimental effects (de Moffarts et al., 2005; Williams et al., 2002).  Antioxidants are 
compounds that interact with the ROS and render them neutral, for example Vitamin E, 
which interacts with superoxide to form the relatively innocuous tocopherol radical, 




Evidence exists for increased oxidative stress in equine laminitis, as non-exercised, 
chronically laminitic ponies were shown to have increased urinary TBARS, a marker of 
lipid peroxidation damage, as compared to non-laminitic ponies (Neville et al., 2004).  
While tissue ischemia and reperfusion are associated with a massive increase in the 
production of ROS (Droge, 2002), the oxidative stress found in chronic laminitis was 
hypothesized to result from underlying IR (Neville et al., 2004).  While this hypothesis 
remains untested, horses with equine Cushing’s disease, a disease associated with obesity 
and a high risk of laminitis, had minimally increased oxidative stress levels and resting 
hy
Equine insulin resistance 
 
perglycemia (Keen et al., 2004).  However, it is most likely that increased oxidative 
stress in the obese horse is not causative of laminitis but rather increases the risk of the 
disease following an appropriate stimulus.  Indeed, Treiber and colleagues (2007) found 
no difference in oxidative stress markers in previously laminitic ponies as compared to 
non-laminitic ponies. 
 
Insulin resistance in the equid was first discussed by Argenzio and Hintz (1971), who 
reported that reduced glucose tolerance in the fasted pony was not due to insulin 
insufficiency but rather resistance to insulin’s action.  While fasting and feed restriction 
are both known to induce IR in the horse and pony (Powell et al., 2000; Sticker et al., 
1995), glucose intolerance has since been associated with developmental orthopedic 
disease (Ralston, 1996), diets high in starch and sugar (Williams et al., 2001; Hoffman et 




1983).  Differences in susceptibility to IR exist within the equine breeds, however, with 
ponies generally exhibiting a greater degree of glucose intolerance than horses (Jeffcott et 
al., 1986).   
The progression from normal glucose tolerance to IR in the fat pony seems to mimic 
tha
s used to determine the divisions between 
eac
s excessive pasture fructans or grain overload (Johnson et al., 2002; Treiber et al., 2006).  
In the pony, laminitis is associated with reduced SI (Coffman and Colles, 1983; Jeffcott 
t found in the obese human.  Freestone and colleagues (1992) divided obese ponies 
with abnormal responses to an OGTT into three groups based on their pancreatic insulin 
response.  The first group exhibited hyperinsulinemia and euglycemia, hypothesized by 
the authors to indicate pancreatic compensation for tissue insensitivity to insulin.  The 
second group was both hyperglycemic and hyperinsulinemic, possibly signifying that 
excessive insulin secretion was no longer able to maintain euglycemia.  The final group 
was hyperglycemic but with normal insulin levels, suggesting that pancreatic exhaustion 
may have been occurring.  While the boundarie
h group were somewhat arbitrary, pancreatic compensation for IR has since been 
observed using direct measures of the insulin response to glucose in relation to SI in both 
laminitic ponies (Treiber et al., 2005b) and horses of BCS ≥ 7 (Hoffman et al., 2003).  In 
addition, horses with excessive adiposity and evidence of pancreatic compensation for IR 
were found to rely more heavily on glucose-stimulated glucose uptake than lean horses, 
most likely to offset the decreased proficiency of insulin-stimulated glucose uptake 
(Hoffman et al., 2003). 
Insulin resistance in the equine has been postulated to act as a contributor to the onset 





et al., 1986; Treiber et al., 2005b) and obese-laminitic ponies have been shown to be even 
ss sensitive to insulin than obese non-laminitic ponies (Jeffcott et al. 1986; Treiber et 
al., 2005b).  Insulin resistance and obesity have been recognized as significant risk 
factors for laminitis in the pony (Treiber et al., 2006) but as yet remain tentative in the 
horse.  Meta-analyses of laminitis cases from several university veterinary clinics found 
that obesity was associated with a greater risk of laminitis in the horse (Alford et al., 
2001) and parallels have been drawn from the pony to include IR as an additional 
laminitic risk factor in the horse.   
Insulin resistance is not believed to be a primary cause of laminitis in the equid.  
Instead, IR and associated conditions, such as oxidative stress and inflammation, are 
believed to increase the risk of laminitis through insidious damage to hoof structures, 
increasing the probability or severity of a laminitic episode.  Both the laminae and the 
vasculature of the hoof are currently thought to be the primary strategic points where 
weakness is exploited.   
Because glucose is not adequately taken up into the tissue during IR, a certain level of 
glucose deprivation may occur.  In the hoof, glucose deprivation leads to weakening of 
the laminae, shown in vitro by French and Pollitt (2004).  Hoof lamellar tissue incubated 
in media that lacked glucose had a weaker resistance to mechanical tension than did 
tissue incubated in glucose-rich media.  Further weakening of the laminae may be due to 
upregulation of the matrix metalloproteinases (MMPs), enzymes responsible for tissue 
remodeling through degradation of the basement membrane of collagenous tissues 
(Mungall et al., 1998).  When laminitis is induced experimentally, two MMPs are 






inistration reduces arterial blood 
ressure in laminitic ponies (Coffman and Colles, 1983) as does glyceryl trinitrate, a 
nitric oxide precursor (Hinckley et al., 1996).  
Increased production of TNF-α may also contribute to the risk of laminitis, both 
insidiou
ociated with both IR and laminitis in horses affected 
with equine Cushing’s disease and increased 11-β-HSD-1 activity has been observed in 
equine skin and lamellar tissue following the induction of laminitis (Johnson et al., 2004).   
ivity and is unable to suppress its activity in human obesity-associated IR (Dandona et 
al., 2003).  In human studies, insulin has been shown to suppress the activity of MMP-9, 
indicating that the IR associated with obesity may be linked to the upregulation of the 
MMPs (Dandona et al., 2003).  
In addition to its primary involvement with glucose metabolism, insulin, in 
conjunction with nitric oxide, also acts as a vasodilator.  In humans, IR is associated with 
endothelial dysfunction and arteriosclerosis (Wilcox, 2005).  During laminitis, tissue 
ischemia caused by vasoconstriction leads to tissue necrosis and coffin bone separation.  
It follows then that insulin’s inability to improve vascular function during IR may be 
contributory to the progression of laminitis.  Insulin adm
p
sly through inhibition of nitric oxide in the obese horse (Lyon et al., 2003) and 
directly through the ability of the inflammatory immune response to cause IR (Fitzgerald, 
2004).  Additionally, heightened TNF-α production in human obesity increases the 
activity of 11-β-hydroxysteroid dehydrogenase-1 (11-β-HSD-1), an enzyme responsible 
for converting inactive cortisone to active cortisol in peripheral tissues (Hochberg et al., 





Dietary impacts on insulin sensitivity 
 
responsiveness and eventual pancreatic exhaustion (Kopp, 2003).  In addition, insulin 
Although excessive FFA metabolism is associated with IR, fatty acid intake at ≤ 3
Insulin sensitivity is impacted not just by obesity but by dietary factors as well, 
sometimes in the absence of excessive adiposity.  Chronic hyperinsulinemia results after 
prolonged exposure to diets high in non-structural carbohydrates, leading to β-cell over-
promotes FFA uptake and persistent high FFA levels are toxic to the pancreas, decreasing 
insulin secretion, increasing β-cell apoptosis, inhibiting insulin gene expression and 
interfering with IRS-1 activation (Grill and Qvigstad, 2000; Wilcox, 2005; Zhao et al., 
2006).  
0% 
of the total diet is not detrimental to SI or the ability of glucose to affect its own uptake in 
humans (Lovejoy et al., 2002).  In horses, this may be the reason why few reports of IR 
associated with high fat diets exist in the literature.  Dietary fat consumption was 
associated with impaired SI in two equine studies (Schmidt et al., 2001; Frank et al., 
2005), but subsequent research into high fat diets has not supported these findings.  High 
fat feeding was associated with impaired glucose tolerance in eight Shetland pony 
geldings fed a diet containing 20% of DE as fat from soybean oil (Schmidt et al., 2001).  
No appreciable weight was gained by the ponies and the authors did not hypothesize 
about the nature of the glucose intolerance.  Frank et al. (2005) found reduced SI in 
ixed-breed Quarter Horse-type mares fed a commercial sweet feed top-dressed with 
250 mL of oil (corn or rice bran).  However, the authors attributed the reduction in SI to 
the sweet feed, hypothesizing that the level of fat was not high enough to affect the 





  Diets high in non-structural carbohydrates (NSC; starches and sugars) are associated 
with post-prandial glucose and insulin responses that are greater than those of forages 
lone or fat-supplemented rations (Stull and Rodiek, 1987; Pagan et al., 1999; Williams 
 et al., 2003).  While long-term consumption of diets high in NSC leads 
to dietary adaptation and an improved ability of the horse to tolerate such diets (Hoffman 
et 
Onset of insulin resistance 
significant genetic component to the development of IR and laminitis, with ponies being 
wever, obesity is a known factor associated 
with laminitis in horses (Alford et al., 2001) and it is possible that a genetic component 
exists within the horse as well. 
associated laminitis in horses is difficult, if not impossible.  In the pony, more accurate 
In the horse however, such evidence is lacking.  It has been shown in other species that SI 
a
et al., 2001; Ropp
al., 2003b), overall SI is reduced when compared to diets where the NSC has been 
replaced by fat and fermentable fiber (Treiber et al., 2005; Hoffman et al., 2003).  In 
addition to a reduction in SI, weanling horses fed a diet high in NSC had increased β-cell 
compensation, indicating that they were able to compensate for the reduced SI through 
increased insulin secretion (Treiber et al., 2005).  
 
 
A common observation among horse owners is that not all obese horses and ponies 
become laminitic.  As with human IR (Alford et al., 1998), there appears to be a 
highly susceptible (Treiber et al., 2006).  Ho
The inability to predict both the susceptible individual and the time-course of obesity-




decreases with increasing body weight, with dogs overfed energy by twice the 
recommended level showing at 44% increase in body weight with a concomitant 45% 
decrease in SI (Gayet et al., 2004).  Rocchini et al. (1997) performed weekly HECs on 
dogs gaining weight on high fat diets and found that SI decreased as soon as one week 
following diet initiation and reached a nadir by two weeks.  As the dogs fed fat in this 
study were gaining weight, as compared to the control dogs which did not gain weight, it 
is unclear as to whether the true source of the reduced SI was due to diet or BW.  
However, Rocchini and colleagues (1987) indicated that previous published work shows 
reduced glucose tolerance in dogs due to high fat diets alone.  In cats, previous IR in lean 
individuals was associated with an increased risk of development of diabetes following 
weight gain to obesity (44% BW increase, 50% SI decrease; Appleton et al., 2001).   
As not every obese horse will become IR and laminitic, not every obese human will 
become IR and diabetic.  A wide range of SI exists within the human population 
(Hollenbeck and Reaven, 1987) and would be expected to occur in the equine population 
as well.  In humans, it is thought that the ability of an individual to compensate for the 
negative physiological effects of obesity will ultimately determine whether or not glucose 
tolerance can be maintained (Reaven, 1988).  So too in the horse, the ability to adapt to 
diets high in NSC or high levels of adiposity may be dependent on the genetic 





PART III: EQUINE DIABETES AND METABOLIC SYNDROME 
 
The IR associated with obesity and laminitis in the horse may not be the same as Type 
II 
insulin-dependent (Type I), non insulin-dependant (Type II) and secondary (S), occurring 
in 
Specific reports in the attainable literature attribute clinically abnormal glucose or 
Equine diabetes 
 
diabetes in humans, dogs and cats.  True type II diabetes is defined as chronic fasting 
hyperglycemia, impaired insulin action, either through under-secretion or over-secretion, 
polyurea, polydypsia and weight loss, with long-term effects such as ketosis, retinopathy, 
neuropathy, etc. (Expert Committee, 2003).  Fasting hyperinsulinemia is not universally 
observed, in many cases due to insufficient insulin secretion for the level of plasma 
glucose. 
Stogdale (1985) defines diabetes in animals as fitting in to one of three categories: 
response to a primary disease.  According to Stogdale, neither Type I nor Type II 
diabetes had been described in the horse through the mid 1980’s.  In fact, up to 1985, the 
24 reports of equine ‘diabetes’ in the literature were all attributable to pituitary tumor or 
pancreatitis (Stogdale, 1985).   
insulin levels in horses to diabetes (Baker and Ritchie, 1974; Ross et al., 1983; Stogdale, 
1985; McCoy, 1986, Ruoff et al., 1986, Muylle et al., 1986 and Johnson et al., 2005).  
Before a definitive diagnosis was (in most cases) confirmed through necropsy, horses 




symptoms including but not necessarily encompassing, weight loss, polyurea, polydypsia, 
fasting hyperglycemia or hyperinsulinemia or both and hirsutism.  Following necropsy, a 
pituitary tumor was found to be the culprit in two cases (Baker and Ritchie, 1974; Garcia 
and Beech, 1986) and pancreatic hyperplasia due to adenoma in another (Ross et al., 
19
 
primary cause of diabetes (Johnson et al., 2005).  Although it is tempting to suggest a 
diagnosis of Type II diabetes, especially in the fourth case, concerns raised by Kronfeld 
et al., (2005) regarding standardized methodology and adequate experimental design 
prevent this from being realized.  Johnson et al. (2005) attempted to quantify the IR 
observed in a domesticated Spanish Mustang through glucose and insulin tolerance tests, 
culminating in a diagnosis of Type II diabetes after noting histological β-cell 
abnormalities that could explain the aberrant insulin and glucose dynamics.  However, 
the strong evidence and assertive claims put forth in the study were not backed up by 
sound experimental design (Kronfeld et al., 2005), bringing the conclusions into question.  
Studies by Ruolf and colleagues (1986) and Muylle et al. (1986) documented both fasting 
hyperinsulinemia and hyperglycemia and Muylle and colleagues observed impaired 
glucose tolerance following oral glucose and meal tolerance tests.  However, neither 
83).  Cancer may have been responsible for a fourth case, a mare with bilateral ovarian 
granulosa cell tumors, but the authors were unclear as to how this would contribute to IR 
in such a case (McCoy et al., 1986).  In several cases, the cause of the symptoms was 
unknown, with one horse testing negative for pituitary, pancreatic and adreno-cortical 
tumors, and a second and third euthanized without necropsy (Ruoff et al., 1986; Muylle 





Several terms exist to describe those equids which are obese, insulin resistant and at 
high risk for the development of laminitis.  Such terms include equine syndrome X 
(Kronfeld and Harris, 2003), equine grain-associated disorders (EGAD; Kronfeld and 
Harris, 2003), the equine Metabolic Syndrome (Johnson et al., 2002), peripheral 
Cushing’s syndrome (Johnson et al., 2002) and pre-laminitic metabolic syndrome 
(PLMS; Treiber et al., 2006).  Each term, however, can be more specifically applied to a 
subset of horses within the general population and it may be that no one label is adequate 
to describe every case. 
, colitis, diarrhea, gastric ulcers, laminitis, exertional rhabdomyolysis, 
osteochondrosis, growth rate fluctuations, flexure deformities, hyperlipidemia, oxidative 
stress, aging, obesity and abortion (Kronfeld and Harris, 2003).  Its attractiveness, 
however, is in that it provides for a simple management strategy, namely the avoidance of 
high starch and sugar feeds.  Because simple caloric restriction due to the removal of 
high-starch grain-based concentrates from the horse’s diet can improve both body weight 
dy confirmed the presence of insulin resistance to a degree necessary to diagnose Type 
II diabetes (Kronfeld et al., 2005). 
 
The equine Metabolic Syndrome 
 
‘Equine grain-associated disorders,’ has been previously favored due to its 
encompassing definition, “a group of digestive disturbances commonly involving rapid 
fermentation and a set of metabolic disorders probably involving insulin resistance 





and IR, a diagnosis of EGAD may be appropriate for use by the general horse owner.  
However, the recent identification of risk factors specific to the onset of laminitis in the 
obese, IR population, the need for a specialization within the grain-associated disorders 
specifically related to obesity and IR is warranted.  
Under the umbrella of EGAD, several labels have been defined to address horses 
specifically at risk for laminitis.  The term ‘peripheral Cushing’s syndrome’ has been 
popular but is misleading in that the comprehensive profile of these animals is in fact 
distinct from those afflicted by true Cushing’s Disease (see McCue, 2002).  The equine 
Syndrome X and equine Metabolic Syndromes were developed to mirror terms 
widespread in the human literature (see Reaven, 1988).   
In humans, Syndrome X was defined as abnormal glucose tolerance and one or more 
of the risk factors for cardiovascular disease (CVD; e.g. hypertension; Reaven, 1988).  
This definition was later widened to include central obesity and renamed the Metabolic 
Syndrome, a definition championed by the World Health Organization (WHO, 1999).  
The WHO defines the human Metabolic Syndrome as an individual diagnosed with 
lucose intolerance, type II diabetes mellitus or insulin or both resistance coupled with at 
ast two of the following risk factors: impaired glucose regulation, diabetes, insulin 
resistance as determined using the euglycemic-hyperinsulinemic clamp (HEC), 
hypertension, raised arterial blood pressure, hypertriglyceridemia, central obesity or 
microalbuminuria (WHO, 1999).  The Metabolic Syndrome is used throughout the world 
as a powerful diagnostic tool for physicians to identify persons at risk for diabetes or 






In order for an equine to be labeled as having the equine Metabolic Syndrome, it is 
recommended that the animal must meet the qualifications set forth by the World Health 
Organization (WHO) for the human Metabolic Syndrome (Kronfeld, 2003; Frank et al., 
2006).  Treiber et al. (2006) lists key risk factors for the development of laminitis as IR 
 hyperinsulinemia, hypertriglyceridemia and obesity, as well as a 
nd access to diets high in starch.   
 of this, Reaven (2006) suggests taking a step back from the ultimate 
diagnosis of
with compensatory
genetic predisposition (e.g. pony breeds) a
It is the goal of such diagnostic tools to identify individuals at risk for developing the 
ultimate disease through the presence of risk factors that predict with certainty the onset 
of said disease.  However, it has become clear from human studies that certain 
individuals who present with various components of the Metabolic Syndrome do not fit 
the total criteria due to the absence of one or more symptoms (Reaven, 2006).  The 
symptoms presented by these individuals may still be taken together to indicate a strong 
risk of developing CVD or diabetes but may not be appropriately labeled the Metabolic 
Syndrome.  Because
 Metabolic Syndrome and instead identify individuals with IR, a strong risk 
factor for the onset of symptoms of the Metabolic Syndrome.  Diagnosing individuals 
with IR as opposed to Metabolic Syndrome allows for circumventing an absolute 
diagnosis of Metabolic Syndrome while still identifying individuals at risk for diabetes or 
CVD.  
So too with equids, a desire to identify at-risk animals may require identification of 
both individuals fitting the specific criteria of the equine Metabolic Syndrome and those 
which can be diagnosed with IR but do not fit all of the required categories for true 




examining the Pre-laminitic Metabolic Syndrome (PLMS; Treiber et al., 2006), which 
lists key risk factors for the development of laminitis as IR with compensatory 
hyperinsulinemia, hypertriglyceridemia and obesity, as well as a genetic predisposition 
(e.g. pony breeds) and access to diets high in starch.   
A need then arises to adequately deal with those animals not fitting all of the above 
cri
may improve the detection, diagnosis and treatment of afflicted horses.  
Gu
 
teria but which still are at risk for the development of laminitis.  Such an example may 
be the obese light horse with IR.  He cannot be diagnosed with PLMS but may still be at 
risk of developing laminitis, especially if he is offered a high-starch diet.  The diagnosis 
of IR will aid the owner and veterinarian in the preventative measures that should be 
taken to adequately manage the health of the horse.  Those horses not fitting the criteria 
of PLMS, namely light-horse breeds with frank obesity and IR, may be better identified 
as having the ‘equine Insulin Resistance Syndrome’ (eIRS; Kronfeld and Harris, 2003), a 
term that 
idelines are currently being developed for the care and management of ponies with 






PART IV: MODULATION OF INSULIN SENSITIVITY THROUGH 
INTERVENTION 
Insulin sensitivity is improved in obese humans following weight loss (Ferranini et al., 
20
 and exercise with or without concurrent weight loss (Freestone 
et 
 
Diet and exercise 
 
While numerous approaches to improving the health of the horse with obesity, IR or 
laminitis have been recommended (Johnson, 2004b), limited research exists on the 
specificity of such treatments in the horse (Kronfeld et al., 2005).  Many ‘common sense’ 
recommendations have been put forth, including weight loss through feed reduction and 
increased exercise, as have those based on current research into the effects of diet on SI 
and laminitis.  However, research into dietary supplements and pharmaceuticals still 
remains in the initial stages and as such should be considered secondary to the common 
sense approaches.  
04).  While improvements have also been seen through dietary restriction, exercise and 
pharmaceutical intervention, the exact mechanisms by which IR is reversed are mostly 
unknown.  In the human, aerobic exercise improves SI through increasing GLUT4 
expression and translocation, and improving IRS-I signaling (Henricksen, 2002). In the 
horse, dietary restriction
al., 1992b; Powell et al., 2002) have been shown to improve SI.  Previously ad libitum-
fed hyperinsulinemic ponies (BCS 7 – 9) placed on a controlled, maintenance feeding 




(Freestone et al., 1992b).  In obese mares (BCS 8 – 9), short-term, low-intensity exercise 
(30 min  trot, HR 120-140 bpm) resulted in a 60% improvement in SI as measured by the 
HEC, when compared to obese sedentary mares, even without concurrent weight loss 
(Powell et al., 2002).  Submaximal exercise (treadmill 5d/wk for 10min, HR ≤ 140 bpm) 
also improved SI in ponies measured by the OGTT (Freestone et al., 1992b).  
While feed restriction, defined here as a reduction in the level of energy offered to the 
ho
 in the feed offered to the horse, concurrent with increased exercise.  Diets 
hig
rse, will stimulate weight loss, care must be taken to avoid detrimental side effects.  
Significant dietary restriction (50% of maintenance DE) in light horse mares (BCS 6 -7) 
resulted in impaired glucose tolerance, with restricted mares having larger insulin and 
glucose responses to an IVGTT (Sticker et al., 1996).  In ponies, rapid weight loss can 
induce hyperlipaemia, in which excessive triglyceride mobilization from adipose tissue 
results in fatty infiltration of the liver, a potentially life-threatening condition (Hughes et 
al., 2004). 
The best recommendation for weight loss and improved SI in the horse is to alter the 
ingredients
h in fat and fiber have been previously shown to increase SI (Treiber et al., 2005; 
Hoffman et al., 2003).  Adding to the positive effect of dietary fat, the addition of beet 
pulp can also assist in increasing SI as it is theorized to cause increased fermentative 
propionate-derived glucose and increased lipoprotein lipase activity (Hallebeek and 
Beynen, 2003).  The simplest recommendation to owners of obese horses is to remove 
energy-dense grain-based concentrates from the horse’s diet and replace it with forage, 
providing no less than 75% of the energy required for maintenance and at an amount no 






The use of pharmacological agents to reduce BW and improve SI in the horse is a 
relatively new area of research and should be considered secondary to diet and exercise. 
hypothyroidism is not a cause of obesity as discussed above, 
dministration of levothyroxine sodium to euthyroid, normal horses resulted in weight 
los
ts (Johnson et al., 2005). 
Although primary 
a
s and improved SI (Sommerdahl et al., 2005; Frank et al., 2005b). Improvements in SI 
were also observed in a horse treated with metformin, a drug used to treat human insulin 
resistance, in concert with glyburide, an anti-hyperinsulinemia compound (Johnson et al., 
2005).  The mare had been diagnosed with hyperglycemia during an IVGTT (>400 
mg/dL for up to 12h), hypertriglyceridemia, polydipsia and glycosuria  Following 
metformin and glyburide administration, glucose levels fell to within the reference range 
for normal horses (72-114 mg/dL) by 4h (Johnson et al., 2005).  The mare was not obese, 
however (BCS 3) and histopathology indicated a reduced number of β-cells within the 
pancreatic isle
Conflicting results using metformin were reported by Vick et al., (2006) in mares 
treated with a low dose (3 g/d) of metformin.  During a dose-response study, SI was 
increased in mares treated with 3 g/d of metformin but not in mares treated with 6 or 9 
g/d.  However, successive use of the 3 g/d dosage failed to improve SI when used in a 
subsequent experiment. 
Clenbuterol is a β-2 adrenoceptor agonist which facilitates anabolic tissue 
repartitioning, specifically a reduction in adipose tissue via increased lipolysis and an 




treat chronic obstructive pulmonary disease, administration of pharmacological levels of 
clenbuterol to Standardbred mares (BCS 5.4) decreased the ultrasound-derived percent 
ody fat of the mares from approximately 21% to approximately 10%, but without a 
concurrent change in BCS (BCS 5.6; Kearns et al., 2001).  Although not measured in this 
following clenbuterol treatment (Pan et al., 
001), which may be an added benefit to treatment with this drug.   
An additional β-adrenergic agonist, ractopamine hydrochloride, tended (P=0.09) to 
enhance BW reduction in treated mares on a restricted feeding regimen (75% of ad 
libitum intake, n=5; Buff et al., 2006).  However, no impact on leptin or insulin was 
observed.  Caution must be taken, however, when considering the use of such β-
adrenergic agonists as therapeutic treatments for obesity.  Mares treated with clenbuterol 
for an 8 week period were at an increased risk for aortic rupture compared to untreated 
mares (Sleeper et al., 2002), indicating that administration of such drugs at 
pharmacuetical doses, which are much higher than therapeutic doses, may not be 
advisable. 
arch 
indicating improved glucose tolerance following treatment (Ott and Kivipelto, 1999).   
Administration of chromium tripicolinate to Thoroughbred (n=11) and Quarter Horse 
(n=13) yearlings of mixed sex resulted in a faster glucose clearance rate during an 
IVGTT, with no difference in body fat between treatment groups (Ott and Kivipelto, 
1999).  Chromium is believed to act at the level of the insulin receptor to aid in proper 
cellular signaling via increasing the activity of several components of the signal 
transduction cascade, including IRS-1 (Wang et al., 2006). 
b
study, research in rats has shown improved SI 
2









Numerous methods of quantifying SI exist in the literature, ranging from simple 
fasting blood samples to highly sophisticated and complex methodologies.  Each have 
been pioneered through human medicine and validated for use in the horse, with some 
techniques faring better than others for diagnosing IR in equids.  The simplest strategy 
for assessing glucose and insulin dynamics consists of taking a single fasting blood 
sample and measuring serum insulin and plasma glucose.  Although these diagnostic 
too
veterinarians.  Although not as accurate as direct measures of SI, these proxies were 
ls are attractive in their simplicity, caution must be taken due to inconsistent results in 
the literature as well as a lack of specificity as to where the resistance lies (Kronfeld et 
al., 2005b).   
Recently, equations have been published allowing simple fasting glucose and insulin 
levels to more accurately reflect the SI status of the horse (Treiber et al., 2005c).  Derived 
from the more complicated methods used to measure SI (the FSIGT, described below), 
these non-specific ‘proxies’ have been shown to accurately estimate both SI and the acute 
insulin response to glucose, indicative of the level of initial responsiveness of the β-cell 
to glucose.  Through these tests, horses which are compensating for IR through increased 




found to be as accurate and comparable to proxies used in human diagnostics, including 
the HOMA-IR and QUICKI (Treiber et al., 2005c). 
ral and intravenous glucose tolerance tests 
 
The IVGTT is considered a more appropriate test of glucose removal from the 
bloodstream due to the bypassing of the gastro-intestinal tract.  When the IVGTT is 




The increased complexity of the OGTT and IVGTT lend themselves to better 
approximation of the degree of IR, although as with the simple indices, the ultimate 
location of the defect, be it at the β-cell or peripheral tissue, cannot be determined 
(Kronfled, 2005).  An additional weakness of the OGTT is that an accurate assessment of 
glucose tolerance may not be possible, due to absorptive differences of the equine 
gastrointestinal tract (Kronfeld, 2005).  This same factor most likely hinders results 
gained from meal glycemic response tests, where instead of a glucose bolus, horses are 
fed a standard meal of oats or concentrate and the glucose response is measured.  The use 
of a meal glycemic response test is best used to estimate the relative changes in blood 
glucose in response to various feeds, similar to the human glycemic index, and is more 
appropriately used by horse owners when deciding which feed is best for their horse. 
 bolus, read from the part of the curve prior to insulin administration, and 
exogenous insulin further facilitating glucose removal can be estimated (Kronfeld, 2005).  
The combined glucose and insulin test (CGIT) combines the IVGTT and an insulin 







also non-specific test because it only shows the presence or absence of resistance and 
gives no quantitative values for SI (Frank et al., 2006). 
 
Modern methods: the euglycemic-hyperinsulinemic clamp 
 
Moving into more sophisticated techniques, the euglycem lamp 
(HEC) directly estimates SI under hyperinsulinemic steady-state conditions (Defronzo et 
al., 1979).  The rate of infusion of glucose under hyperinsulin c di s rectly 
proportional to SI.  Information on insulin secretion and β-cell function can be derived 
from an adjustment in the protocol to attain hyperglycemia, while m uring changes in 
endogenous insulin secretion. 
Long considered the ‘gold standard’ for measuring SI in hum a o  
experimental models, the HEC is both labor-intensive and com , h st constant 
glucose monitoring and flow adjustment required for adequate as m o .  
additional drawback of the HEC is that it does not reflect in v h es l e  
insulin following bolus administration, as it is a steady-state approxima  o u  
and insulin dynamics (Bergman, 1997).  In order to evaluate glucose and insulin 
dynamics in a non-steady state system, a modification of the IVGTT can be used, 
wherein numerous blood samples are taken following insulin us  5) o  
by mathematical modeling of the glucose and insulin responses.  The frequently-sampled 
intravenous glucose tolerance test (FSIGT), with SI derived c ro n  
ic-hyperinsulinemic c
emi con tion is di
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ans nd ther
plex  wit almo
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Modern methods: the minimal model of glucose dynamics 
 
The minimal model of glucose (and insulin) dynamics describes the changes in plasma 












model of glucose dynamics, was proposed in 1979 as an alternative to the HEC (Bergman 
et al., 1979). 
ical glucose responses to insulin.  Insulin and glucose concentrations over a 180-240
inute sampling protocol are entered into computer software (MinMod Millenium,
oston et al., 2003), and are integrated to produce estimates of SI and other important 
eters.  The intent of the original minimal model protocol was to mathematically
escribe the complex dynamics of glucose and insulin in the bloodstream from a simple
linical test, the FSIGT (Bergman, 1997).  Using the multiple sampling protocol, four
hases of glucose dynamics were discerned: the initial mixing of glucose in the
tribution space (plasma), glucose uptake prior to insulin effects, accelerated glucose 
uptake via insulin action and the return to baseline (Bergman, 1997).  A primary 
assumption of the minimal model is insulin’s action from a ‘remote compartment,’ the 
interstitial space, instead of serum or plasma.  Additionally, the model accounts for the 
effect of glucose on its own utilization, Sg, and the suppression of hepatic glucose output 
by both glucose and insulin (Figure 6; Bergman et al., 1979; Bergman, 1997). 
Using knowledge of glucose kinetics, the minimal model can estimate both SI and 
-cell function, previously only measurable under the purview of the HEC, as well as
lucose-stimulated glucose disposal (Sg) and the acute insulin response to glucose AIRg), 
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Since its inception, the minimal model has seen several variations.  Originally 
 a ulty in estimating SI in advanced type II 
diabetes required the addition of tolbutamide, an insulin secretagogue, or exogenous 
insulin, at a time point beyond the initial insulin response (Beard et al., 1986; Saad et al., 
1997).  Additionally, somatostatin injections prior to glucose administration have been 
used to suppress the endogenous insulin response (Yang et al., 1987) and labeled glucose 
has been infused (Ader et al., 1997), both in attempts to quantify Sg. 
 up to 
s acceptable (Finegood, 1997) and that more samples were necessary if 
e study had a small number of experimental units (Steil et al., 1994).  The 
od, 1997) was chosen due to good 
peatability and correlations between studies and has also been used successfully in 
al., 1990; Finegood, 1997).  However, 
del was compared to the HEC several times, with each independent study finding a 
significant, high correlation between SI measured by the two methods (r = 0.85, P < 
0.002; Beard et al., 1986), (r = 0.89, P < 0.001, Bergman et al., 1987) indicating that the 
minimal model was an acceptable substitute for the HEC.  In fact, when SI data from 
both methods are expressed in identical units, the two methods were found to be 
equivalent (Bergman et al., 1987). 
designed with only  glucose bolus, diffic
The original FSIGT required numerous samples (at least 30) taken over 180 minutes 
following the glucose bolus.  Research on different sampling strategies found that
240 minutes wa
th
recommended glucose dosage (300 mg/kg, Finego
re
horses (Hoffman et al., 2003; Treiber et al., 2005; 2005c).  Concerns have arisen as to 
this dose exceeding the renal threshold, the point whereby the kidneys begin to remove 
excess glucose, which would lead to improper estimation of glucose disappearance, 




glucose levels exceeding the renal threshold would only be apparent during the first few 
minute
the MinMod software as they only represent mixing of glucose in the plasma (Boston et 
al., 2003). 
 (Treiber et al., 2005), 20 mU/kg (Treiber et al., 
005c; Quinn et al., 2007) and 30 mU/kg (Hoffman et al., 2003).  Administration of both 
een shown to be appropriate in 
llowing descriptions have been independently drawn 
K.H. 
reiber, Virginia Polytechnic and State University, Blacksburg, VA, personal 
co
equations.   
s following glucose administration, and these points are excluded from analysis in 
The insulin dose is recommended to be low enough to prevent receptor saturation, but 
high enough to elicit a response that can be fit by the computer software (Prigeon et al., 
1996).  As the amount of insulin administered has been shown to affect the estimate of SI 
(Welch et al., 1990), an attempt should be made to standardize the dosage.  In horses, the 
insulin doses have been 1.5 mU/kg
2
glucose and insulin is done on a kg BW basis, which has b
human studies (Finegood, 1997). 
Defining the equations 
 
Defining the equations.  The fo
from Bergman et al. (1979), Bergman (1997), Boston et al. (2003) and Treiber (
T
mmunication).  The estimation of SI from the minimal model relies on the accurate 
description of changes in both glucose and insulin in response to their respective bolus 
and obtaining ‘best fits’ of the model to the data (Boston et al., 2003).  Through the use 
of non-linear differential equations, changes in insulin and glucose in the serum and 




The minimal model equations were developed to provide the simplest description of 
the change in glucose in relation to the change in insulin, beginning in the absence of 
ins
Equation 1 
quation (1).  When the contribution of insulin is insignificant, such as during advanced 
r during the lull between glucose dosing 
ulin-
dependent mechanisms (Sg).  At basal, a steady state is achieved through the ‘input’ of 
he
e glucos  bolu increased over basal and after glucose 
g is 
co  contribution to glucose loss will decrease as insulin 
levels increase.  Equation 1 in its final form is:     
ulin and increasing in complexity as factors influencing glucose loss are added.  Each 
equation has two components, ‘input’ and ‘loss,’ which are modified by the influencing 
factor (insulin).  In a steady state, ‘input’ will equal ‘loss’ and during the non-steady state 
FSIGT, the increase in ‘input’ above basal is countered by increasing ‘loss.’  
 
Equation α  ∆G = (input) – (loss) 
E
type II diabetes, suppression by somatostatin o
and endogenous insulin secretion, glucose loss from the circulation occurs by ins
in
patic glycolysis and the ‘loss’ through Sg.  Assuming an insignificant contribution of 
insulin, the loss of glucose from the circulation (mg/dL per minute) is expressed as 
  
 
Equation 1a  G’(t) = (Sg*Gb) – (Sg*G(t)) 
 
Following th  e s, the ‘input’ is 
detection by the pancreas, the ‘loss’ is accelerated by insulin secretion (X).  While S




Equation 1.  G’(t) = Sg * Gb -[Sg + X(t)]G(t)  
        (Bergman, 1997) 
Equation 2 
Equation (2).  The second equation is fundamentally similar to Equation 1, in that the 
change in insulin action within the interstitial space is also impacted by ‘input’ and ‘loss’ 
factors.  The insulin input, I(t), is affected by the efficiency of trans-endothelial transport 
of insulin (P3), indicative of how rapidly insulin responds to glucose stimulation.  The 
ability of insulin action, X(t), to dispose of glucose is dependent on the rate of insulin loss 
from the interstitial space (P2).          
 
Equation 2.   X’(t) = [P3 * I(t) – Ib] –  [P2*X(t)] 
        (Bergman, 1997) 
From equation 2, SI is derived: 
 
Equation 3.  SI = P3/P2 
        (Bergman, 1997) 
 
By studying equation 2, it becomes apparent how SI can be manipulated based on the 
response of insulin to the glucose bolus.   As an example, if insulin action is very high 
and insulin is working as it should, the first half of the equation will become increasingly 
large (very efficient insulin delivery, high concentration).  In addition, clearance will be 








Equation 4.    AIRg = ∫010  [I(t) – Ib]dt 
        (Bergman, 1997) 
 
The degree of compensation by the β-cell, the disposition index (DI), is quantified as 
the product of AIRg and SI and reflects β-cell insulin secretion, corrected for the level of 
SI.  While a standardized reference range of DI has not yet been established in humans or 
horses, the increase or decrease in DI relative to treatment groups and the respective 
changes in SI and AIRg can be used for comparative purposes. 
 
Equation 5.   DI = AIRg * SI  
        (Bergman, 1997) 
Limitations to the minimal model 
uation increasingly small.  As a result, the change in insulin action over time will 
increase, as will SI.   
It is possible to quantify the response of the β-cell to glucose through the minimal 
model equations.  As previously described, the pancreas has the ability to co
uced tissue sensitivity, and thus an individual with low SI may show normal glucose 
tolerance due to an increase in insulin secretion.  Insulin secretion is estimated through 
the response of the pancreas during the first ten minutes of the FSIGT, the acute insulin 
response to glucose (AIRg), which ultimately is a reflection of post-hepatic insulin 




Limitations to the minimal model.  A key limitation to the minimal model is the 
estimation of Sg, which is assumed to indicate the rate of glucose uptake independent of 
glucose.  However, Sg is not truly independent of the actions of insulin as it is measured 
at basal insulin not zero insulin (Kahn et al., 1994).  Even at basal levels, insulin is still 
imp lin 
contribution is derived n and thus estimating 
the glucose effectiveness at zero insulin (GE
estim
overestimate the true value of Sg.    
Aside from the confounding effects of insulin, assuming a constant rate of insulin-
independent glucose uptake may not be entirely correct.  The minimal model assumes 
that glucose is taken up into a single compartment, the easily accessible pool of plasma, 
liver, skeletal tissue and adipose tissue (Caumo et al., 1996).  However, evidence has 
been shown for the existence of two pools into which glucose moves (Caumo et al., 
1996).  In the minimal model, the rate of removal of glucose from the plasma by insulin-
independent mechanisms is assumed to occur uniformly at the rate identified as the 
variable ‘Sg.’  However, ‘Sg’ has been found only to adequately represent glucose 
effectiveness during the initial part of the curve, when glucose is moving into the first 
pool.  Once the insulin effect has waned and glucose has returned to near basal, the 
estimate of Sg is no longer accurate and in fact overestimates the speed of glucose-
stimulated glucose uptake into the second, more slowly equilibrating pool (Caumo et al., 
1996). 
acting glucose uptake and hepatic output.  Estimation of true Sg without insu
 from subtracting out the effect of basal insuli
ZI; Kahn et al., 1994).  Because of this, 




All is not lost however, in that Sg is found to no longer be overestimated during 
advanced IR, such as type II diabetes (Finegood and Tzur, 1996).  As the initial insulin 
response to glucose diminishes with disease progression, its contribution to Sg becomes 
les
The use of the minimal mo y Hoffman and colleagues in 
2003 and has since been used to understand the interplay between body condition, diet, 
ge d 
and th 
the  of 
equine research in gene
 
s influential and the accuracy of Sg increases (Finegood and Tzur, 1996). 
del the horse was validated b
netics and laminitis in several studies.  Adapting a technique that has been validate
 utilized in human diagnostics for almost 30 years to equine research increases bo
accuracy and precision of data collected on IR, as well as improving the quality
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Altered glucose and insulin dynamics, including reduced insulin sensitivity (SI) have 
be
gs (BW 522 ± 15 kg; BCS 4.4 ± 0.1) were fed hay and a commercial 
concentrate twice daily at maintenance for three wk followed by a six wk acclimation to 
the high starch treatment concentrate.  After the sixth wk, an additional 20 Mcal/d above 
maintenance was offered, resulting in an ADG of 0.35 kg/d over 41 wk (total gain 90.8 
kg; final BW 615 ± 15 kg, BCS 6.8 ± 0.1).  To assess SI, frequently-sampled i.v. glucose 
tolerance tests were completed prior to treatment initiation (wk 3), after four wk of 
treatment concentrate feeding (wk 7) and with each 22.7 kg BW gain.  The minimal 
model of glucose and insulin dynamics was used to estimate SI, glucose effectiveness and 
the acute insulin response to glucose.  Leptin, lipid hydroperoxide and glutathione 
concentrations were measured monthly.  By wk 7, SI had decreased (P = 0.04) from 
initial values.  At the end of weight gain, SI and Sg remained unchanged (P = 0.88; P = 
0.84) and the acute insulin response to glucose increased (P = 0.001) compared to wk 7.  
Lipid hydroperoxide and glutathione were unaffected by weight gain (P > 0.05).  Leptin 
increased (P < 0.001) but was not correlated to SI (P = 0.31).  Because the BCS and BW 
gain in this study were not associated with a reduction in SI, increase in oxidative stress 
en observed in overweight horses and may contribute to metabolic disease.  The 
objective of this study was to evaluate SI, leptin, lipid hydroperoxide and glutathione in 
horses during controlled weight gain to determine the point along the continuum of BW 





or leptin resistance, the BCS and BW gain where the risk of metabolic disease is 




 Changes in tissue insulin sensitivity (SI) can result in insulin resistance (IR), where 
the normal level of insulin required to facilitate glucose uptake is no longer adequate 
(Wilcox, 2005).  In the equine, IR is associated with obesity (Hoffman et al., 2003), 
laminitis (Treiber et al., 2005) and leptin resistance (Cartmill et al., 2003).  While horses 
are more insulin sensitive than ponies (Jeffcott et al., 1986), the prevalence of obese 
horses acquiring IR and laminitis is increasing (Johnson, 2002) and it is not known 
whether IR in the horse occurs progressively with increasing adiposity or develops 
following prolonged obesity.   
The onset of IR in the horse may be concurrent with resistance to leptin, a hormone 
secreted from adipose tissue in proportion to fat levels that acts on neural pathways to 
promote reduced energy intake (Arch, 2005).  Because elevated leptin in a group of obese 
horses was associated with an exaggerated insulin response to a glucose challenge 
(Cartmill et al., 2003), changes in SI with weight gain may be mirrored by changes in 
leptin.  In addition, increasing adiposity may increase the risk of cellular damage from 
oxidative stress due to the accumulation of reactive oxygen species (ROS), end products 
of intracellular metabolism that interfere with cell signaling and membrane integrity 
 







nc and Taylor, 2006).  In obese humans, oxidative stress is associated with 
a endothelial function and IR (Vincent and Taylor, 2006) and as such may 
tr  to the pathogen n , 4).   
t  the goal of this c  gain on SI, leptin 
 t arkers of oxidative stress, lipid hydroperoxide (LPO) and reduced (GSH) and 
i (GSSG) glutathione r to iden y the limit of BW gain associated with an 
e  risk of m a i  a level of osity, 
n  as BCS.   
aterials and methods 
MATERI D
ent was run in conjunction with another experiment assessing t  
t gain, diet and exercise on insulin sensitivity in the horse.  The ex  
e ied out at the Universit Mary u R   (Clarksville, MD) 
 t xperimental prot s w a  imal Care and Use 
e at the U ersity of Maryland (Protocol # R - 05 - 16). 
   Thorough d g  f 
 ± k d 4.4 ± 0.1, respec n  stalls  
at flooring and pelleted wood fiber bedding (Woody Pet, Surre .  
h s received routine dental care, vaccinations and deworming -















































































































0900 and 1600 for 35 m
ized salt.  Hay 
was fed twice daily at 0800 and 1900 in floor-mounted wooden hay boxes and orts 
e the concentrate.  Grab samples of concentrate (n = 8) were submitted 
to a comm
transitions were made over a 7d period. 
in at a speed of 1.2 m/s using an automated 6-horse exerciser 
(Priefert, Mt. Pleasant, TX).  
 
Diets.  Prior to the start of the study, horses were maintained in the study facility and fed 
only mixed grass-alfalfa hay for a four wk period.  At the start of the study, horses were 
given three wk to acclimate to a diet of mixed grass-alfalfa hay and a texturized 
commercially available concentrate (CF; Legends 12, Southern States Cooperative, 
Richmond, VA; Table 1) at a level meeting their maintenance requirement for DE and 
providing vitamins and minerals at a level meeting or exceeding the minimum 
requirements for horses (NRC, 1989).   
Throughout the study, all horses had ad libitum access to water and iod
collected and weighed prior to the morning feeding to estimate daily hay intake.  Due to 
the length of the study, three separate lots of hay were fed (Table 1) and three to five 
random core samples of hay taken from each lot were submitted to a commercial forage 
testing lab for nutrient analysis (Dairy One, Ithaca, NY).  Concentrate was offered in 
individual canvas nose bags (Derby Originals, North Canton, OH) and refusals weighed 
following each feeding to estimate concentrate intake, with horses given 45 min during 
which to consum
ecial laboratory  for nutrient analysis (Dairy One, Ithaca, NY).  All diets were 
offered at a ratio of 60% hay to 40% concentrate.  Upon inititation of weight gain (wk 9), 




Table 1. Nutrient analyses  ercial concentrate (CF 2) fed to Thoroughbred geldings for a th w eri at 
start of the study, tr o ed from wk four to the end of weight gain (wk 41), and hay fed t g  t
Data are presented a  








mm ree k p od the 
hrou hout he study.  
Ha
(wk fed) 
Item, % F H Lot 1 
(pre-study to wk 25) 
Lot 2 
(wk 26 to 29 ) 
Lot 
(wk 30 to 41) 
C S 3 
ADF 0 ± 3 04 31.40 ± 0.84 b 39.00 ± 2.21 c 35.05 ± 1.11 bc
NDF 0 ± 2 51.37 ± 2.27 63.00 ± 6.00 50.75 ± 3.00 
NSC 3  ± 0. 6.7 ± 1. 17.47 ± 2.04 13.10 ± 5.39 10.38 ± 2.69 
Fat ± 0. .3 ± 0.1 3.43 ± 0.14 2.40 ± 0.37 2.83 ± 0.19 
CP ± 0. 0.0 ± 0.6 14.35 ± 0.54 11.00 ± 1.44 17.5 ± 0.72 b 
Ca ± 0.0 73 ± 0.10 0.92 ± 0.07 0.69 ± 0.19 0.86 ± 0.09 
P ± 0. 8 ± 0.03 a 0.26 ± 0.03 0.17 ± 0.07 0.31 ± 0.04 























 0.07 2.34 ± 0 04 1.98  0.10 b 
 
1 Dairy One, Ithaca, N
2 Legends 12, Southern
3 NSC = Non-structura ydr d as starch plus sugar (as water-soluble carbohydrates) 
a Means within rows ar ican at P < 0.05 for concentrate 













ent (NRC, 1989).  After six wk, the amount of DE 
ffered was increased to 20 Mcal above maintenance per day to encourage weight gain.  
and the 
quation of  Kane et al. (1987) was used to calculate percent body fat (% fat = 2.47 + 
At wk 4, the horses were transitioned onto the treatment concentrate (HS, Table 2) fed 
to meet their maintenance DE requirem
o
The DE offered was recalculated weekly following the assesment of weight gain to 
account for the increasing maintenance requirement.  While hay lot two was being fed, 
the rate of weight gain began to decline and so a third concentrate feeding was added (at 
1300), which offered an additional 7 Mcal DE per day.  Refusals of hay and concentrate 
were recorded daily and a seven d period at the end of every 4 wk period was averaged to 
estimate intakes of feed and DE.  Data from one horse was not used for intake 
calculations due to excesive urination on refused hay.  Weight gain was terminated at wk 
41 when the average initial BW had increased by 90.8 kg.    
  
Assessment of weight gain:  Horses were weighed every two wk on a livestock scale 
(Preifert, Mt. Pleasant, TX) beginning at wk 1.  BCS was assessed at wk 3, wk 7, wk 9 
and every four wk thereafter by two independent researchers using the Henneke BCS 
system (Henneke et al., 1983).  Each researcher assigned a numerical score (range 1 to 9 
with half-scores possible) to the six different body areas which were then averaged to 
calculate the BCS.  The final BCS was calculated by averaging the BCS scores from both 
researchers.   
At the end of weight gain, rump fat thickness was measured via ultrasound 
e
5.47 (rump fatcm)).  Fat depth was measured 6 cm lateral from the midline at the center of  
Table 2.  Ingredient composition of treatment concentrate (HS) fed to Thoroughbred 
geldings from wk 4 to wk 41.  Concentrate was fed to meet the animals’ maintenance DE 
requirement from wk 4 to wk 9, followed by an increase to 20 Mcal above maintenance 
from wk 9 to wk 41 
Ingredient, % HS 
Corn 56.0 
Oats 12.5  
Distillers grains 7.0 
Soybean meal 5.0  
Beet pulp 5.0  
Vitamin D 0.2  
Molasses 5.0  
Mixed hay 5.0  
Limestone 0.5  
Vitamin E 0.5  
Vitamin, mineral and amino acid premix1 2.3  
Salt and trace mineral premix2 1.0  
 
1 Grass-plus Mineral, Buckeye Nutrition, Dalton, OH; Guaranteed analysis: CP, 8%; 
lysine, 2.5 %; methionine, 1.3%; Ca (minimum) 19%; Ca (maximum) 22%; P, 6%; K, 
2%; Mg, 1.5%; Mn, 900 ppm; Fe, 1150 ppm; Cu, 550 ppm; Zn, 1300 ppm; Co, 15 ppm; 
I, 1
1,760 IU/kg.  
5 ppm; Se, 9 ppm; vitamin A, 176,000 IU/kg; vitamin D-3, 17,600 IU/kg; vitamin E, 
 
2 Harvest salt, Buckeye Nutrition, Dalton, OH; Guaranteed analysis: NaCl (minimum), 
93%; NaCl (maximum), 96%; Mn, 500 ppm; Cu, 2500 ppm; Zn, 5000 ppm; Co, 150 




the pelvic bone using b-mode ultrasound with a 15.24 cm linear transducer and frequency 
of 3.5 Hz (Aloka 500, Tokyo, Japan). 
 
 Blood sampling:  Twenty milliliters of blood was collected by jugular venipuncture 
every 4 wk over the course of the study for the determination of serum leptin, serum 
cortisol, plasma LPO and whole-blood GSH and GSSG.  Samples were taken prior to the 
initiation of weight gain (wk 9), after the fourth wk of weight gain (wk 13) and every 4 
wk thereafter for 41 wk.  For the collection of serum, 10 mL of whole blood was placed 
into an additive-free evacuated glass collection tube (Vacutainer, Becton Dickenson, 
Franklin Lakes, NJ), allowed to clot for 2 h at room temperature and centrifuged at 4°C 
for 15 min at 2000 x g.  For plasma collection, 10 mL of whole blood was placed into an 
evacuated glass collection tube containing EDTA as an anticoagulant  (Vacutainer, 
ecton Dickenson, Franklin Lakes, NJ).  Prior to centrifugation, 100 uL of whole blood 
 determine 
oncentrations of LPO, GSH and GSSG were stored at -80°C until analysis.   
B
was placed into a 1.5 mL microtube (Fisher Scientific, Pittsburgh, PA), to which 10 uL of 
1-methyl-2-vinyl-pyridium trifluoromethane sulfonate (M2VP) was added for later 
determination of GSH concentrations.  The remaining blood from the EDTA tubes was 
immediately centrifuged at 4°C for 15 min at 2000 x g.  Serum and plasma used for the 
determination of hormone and metabolite concentrations were transferred into 1.5 mL 
microtubes and stored at -20°C until analysis.  Plasma and whole blood used to
the c
 
FSIGT: Horses were subjected to frequently-sampled intravenous glucose tolerance tests 




occurred at wk 3, while the horses were consuming the CF concentrate at maintenance 
(CFMM) and the second at wk 7, while the horses were consuming the HS concentrate at 
maintenance (TXMM).  Subsequent FSIGTs occurred with each 22.7 ± 4.5 kg BW gain 
(WG1, WG2, WG3 and WG4).  Following each weekly estimation of BW, total gain 
above maintenance BW was calculated.  After a 22.7 ± 4.5 kg gain was observed, horses 
were scheduled for an FSIGT the following week, with 5 d elapsing between weighing 
and FSIGT.  No more than four horses were scheduled for an FSIGT on any given day.  
By
 as maintain quiet, calm behavior in all horses housed in the barn.   
collected (0730, 0745 and 0759) for determination of basal glucose and insulin levels.  
 wk 41, all horses had completed FSIGTs CFMM through WG3, with only five of the 
nine completing WG4.  
The night before each FSIGT, horses were asceptically fitted with an indwelling 14 
guage jugular catheter with attached 5.5 mL total volume extension set, kept patent with 
12 mL of heparinized saline (0.75 mL heparin/1000 mL isotonic saline).  At 0600 on the 
day of the FSIGT, horses were fed their morning ration of hay only and had access to hay 
and water during the entire FSIGT.  No concentrate was fed to any horse on the morning 
of an FSIGT.  Provision of hay during the FSIGT (Hoffman et al., 2003; Treiber et al., 
2005b) is thought to reduce the effect of fasting on glucose dynamics (Forhead and 
Dobson, 1997), as well
The morning of the FSIGT, horse BW was measured in order to accurately determine 
the level of glucose and insulin to be administered.  Glucose (50% dextrose solution, 
AmTech Group, Inc., St. Joseph, MO) was administered as an i.v. bolus of 300 mg/kg 
BW.  Insulin (HumulinR, Eli Lilly and Co., Indianapolis, IA) was administered as an i.v. 




Intravenous glucose was administered over a 2 - 3 minute period beginning at 0800.  
Thirty-five venous blood samples were taken at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 19, 
2, 23, 24, 25, 27, 30, 35, 40, 50, 60, 70, 80, 90, 100, 120, 150, 180, 210 and 240 minutes 
nalysis of Blood Hormones:  Serum insulin and cortisol were measured in duplicate 
using RIA techniques (Coat-A-Count Insulin and Coat-A-Count Cortisol, Diagnostics 
Products Corporation, Los Angeles, CA), previously validated for use in the horse 
2
after glucose was administered.  Insulin dosing occurred 20 min after the glucose was 
administered.  For each sample, 20 mL of whole blood was immediately transferred into 
one of two glass specimen tubes containing either sodium fluoride/potassium oxalate 
(Vacutainer, Becton Dickenson, Franklin Lakes, NJ) or no additive (Fisher Scientific, 
Pittsburgh, PA).  Blood from the sodium fluoride/potassium oxalate tubes were 
immediately centrifuged at 4° C for 15 min at 2000 x g while blood from the additive-
free tubes was allowed to clot for 2 h at room temperature before being centrifuged at 4° 
C for 15 min at 2000 x g.  Serum and plasma were transferred to microtubes and stored at  
-20° C until analysis.  
 
Minimal Model Analysis: Raw glucose and insulin data were modeled by MinMod 
Millenium (Ver. 6.02, 2001) using equations previously validated in the horse (Hoffman 
et al., 2003).  Variables estimated include SI, insulin-independent glucose uptake 
(glucose effectiveness; Sg), the acute insulin response to glucose (AIRg) and the 
disposition index (DI; Bergman, 1997).  Data from two individual horse FSIGTs were 
excluded from the analysis due to poor parameter resolution (f_sd ≥ 0.5; 3%). 





(Freestone et al., 1991).  Serum lep sured using a double-antibody RIA 






sample and the blank.  The net absorbance was divided by the molar 
tin was mea
p
rse (Buff et al., 2002).  Plasma glucose was measured in triplicate by colorimetric 
assay (Glucose C-2, Wako Chemicals, Richmond, VA), wherein samples were read at 
505 nm on an absorbance microplate reader (Tecan Sunrise, Phenix Research Products, 
Hayward, CA).  The intraassay CV of was 3% for insulin, 3% for cortisol and 5% for 
glucose.  The interassay CV for insulin was 16%. 
The levels of reduced and oxidized glutathione were determined in triplicate using a 
commercially available kit (Bioxytech, GSH/GSSG-412, OXIS Research, Portland, OR).  
Levels of GSSG were measured through an enzymatic reaction of GSH with dithiobis-2-
nitrobenzoic acid, resulting in the conversion of 2-GSH to GSSG.  The rate of color 
change, read at 412 nm every 15 sec over a 3-min period in an absorbance mi
der, was proportional to the change in concentration of GSSG.  Increased accuracy is 
achieved by the addition of M2VP to the whole blood prior to freezing, which scavenges 
any GSH already present and prevents back-conversion to GSSG.  Data were not 
available for wk 3, wk 25 and wk 33 as M2VP was mistakenly not added to the wh
od before freezing. 
For the determination of LPO in plasma, the oxidiation of Fe II to Fe III by LPO was 
quantified via its complexing to xylenol orange (Kinnunen et al., 2005).  The absorption 
of the sample and concurrent blank were measured at 560 nm in an absorbance 








extinction coefficient of LPO (0.0521) to determine the final concentration.   The 
intraassay CV of triplicate samples was 6% for GSSG, 5% for GSH and 4% for LPO. 
 
Statistical Analysis.  All statistical analyses were performed using SAS statistical 
software (v. 9.1, Cary, N.C.).  Assumptions of normality and homogeneity of variances 
were evaluated by examination of the residual plots and found to be m r ariables 
except SI, leptin, basal glucose and LPO.  Variables not meeting m ns were 
adjusted by base-10 logarithmic transformation prior to analysis.  A a les were 
analyzed by repeated measures mixed model ANOVA using orthoganal contrasts for 
least-squares mean comparisons and to test for linear and quadratic changes over time.  
The values for SI, Airg, Sg and basal insulin at CFMM were used as a  for 
all ANOVA analyses, the appropriate correlation matrix for repeated m r as 
chosen based on the smallest Akaike’s Information Criteria.  Fixed m l cts 
included day, treatment and the treatment by day interaction and the o fe as 
horse (within treatment).  Relationships between variables were explored by partial 
correlation analysis adjusted for horse (within horse) using the GLM ed  o S.  
Data are presented as least squared means ± SEM and Tukeys’ HSD test was used for 
least-squares mean comparisons when appropriate.  Although the data for log-normal 
variables are presented as least-squares means ± SEM, significant differences reflected in 
the superscripts refer to the test of significance run on the log-transform
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Average BW and BCS are presented in Figure 1.  At wk 3, average BW was 522 ± 15 
kg (range 466 to 576 kg) and BCS was 4.4 ± 0.1 (range 3.8 to 5.0).  Horses m
BW and BCS through the start of weight gain (BW, 519 ± 15 kg, range 473 to 590 kg, P 
= 0.57; BCS, 4.2 ± 0.1, range 4.0 to 4.6, P = 0.77).  Following the initiation of weight 
gain, average BW and BCS increased (P < 0.0001) to wk 41.  Final average BW
± 15 kg (range 539 to 684 kg) and BCS was 6.8 ± 0.1 (range 6.3 – 7.3).  Regressions of 
BCS on BW and time (data not shown) indicated that an increase of one BCS required a 
gain of 32 kg (r2 = 0.36, P < 0.0001) and required 80 d (r2 = 0.89,  
Ultrasound-derived rump fat depth at the end of weight gain was 2.7 ± 0.2 cm (range 1.8 
– 4.0 cm) and calculated percent body fat averaged 17 ± 1 % (range 12 – 24 %).  
When fed at maintenance, all feed offered was consumed, indicating that the hay and 
both concentrates were acceptable.  Despite small and occasional significant differences 
between weeks, a linear change between wk 9 and wk 41 for both DE intake and ADG 
was not detected (Figure 2; DE, P = 0.29; ADG, P = 0.20).  The ADG was 0.35 kg/d.  
The slight decline in DE intake and ADG at wk 29 coincided with the offering of the 
second lot of hay (hay # 2), which was chemically assessed to be lower in nutritional 
quality.  The additional concentrate feeding added following the wk 33 samp
result in a total DE intake greater than the previous month (P = 0.21) but concentrate 
intake was greater between wk 33 and 37 than during all previous weeks (
not shown). 
aintained 
 was 615 
P < 0.0001). 
le did not 




























Figure 1.  Changes in average BW and S u ed d ( 9) l  m l c t k r m
concentrate (wk 9) at maintenance an o u ei g w 0 1 o ed SEM was 12 kg for BW n 1 B  
abcdefgh Least-squares means within each a w n m u cr d  ( 0.  
ings n =  whi e fed com ercia con entra e (w 3) o treat ent 
k 1 to 4 ).  P ol  a d 0. for CS. 
pers ipts iffer P < 05).
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 (kg/d; n = 9) in Thoroughbred geldings while fed commercial 
Pooled SEM was 1.0 
Mcal for DE and 0.2 kg for ADG.  abc Least-squares means with uncommon superscripts differ (P < 0.05). 
concentrate (wk 3) and treatment concentrate (wk 9) at maintenance and throughout weight gain (wk 10 to 41).  









The target weight gain between each FSIGT was 22.7 ± 4.5 kg and actual average 
weight gain ranged from 17.3 – 24.0 kg.  The increase in BCS between each FSIGT 
ranged from 0.1 – 0.5 scores.  Data for all minimal model variables are presented in 
Table 3.  Between CFMM and TXMM, Sg, AIRg, DI and basal glucose remained 
unchanged (Sg, P = 0.10; AIRg, P = 0.49; DI, P = 0.07; basal glucose, 
log-normal SI and basal insulin were decreased (P = 0.04; P = 0.001).  No linear change 
in log-normal SI, Sg or basal glucose occurred between TXMM and WG4 (SI, 
Sg, P = 0.84; Basal glucose, P = 0.92).  A significant linear increase was found between 
TXMM and WG4 for AIRg (P = 0.01) and basal insulin (P = 0.002) while a quadratic 
effect was found for DI (P = 002).  Neither BCS nor BW were correlate it  (data 
not shown; BCS, r = - 0.132, P = 0.40; BW, r = - 0.12, P = 0.45) but were positively 
correlated with AIRg (data not shown; BCS, r = 0.32, P = 0.04; BW, r = 0.39, P
Log-normal serum leptin increased between wk 9 and wk 41 (P < 0.001; F gure 3) and 
was positively correlated (data not shown) to BCS (r = 0.67, P < 0.001) and B  (r = 
0.59, P < 0.001) but not to SI (r = - 0.038; P = 0.81).  No change was found between wk 
9 and wk 41 for serum cortisol (P = 0.65; Figure 4) or log-normal plasma
Figure 5).  Between wk 9 and wk 41, the concentration of whole blood GSH decreased (P 
= 0.01) while GSSG remained unchanged (P = 0.65; Figure 6). 
P = 0.37) while 
P = 0.88; 
d w h SI
 = 0.01). 
i
W




able 3.  Least-squares means ± SEM for minimal model variables in Thoroughbred geldings derived from a frequently-sampled i.v. 
lucose tolerance test while fed commercial concentrate 1 (CFMM) or treatment concentrate (TXMM) at maintenance and throughout 
eight gain.  Minimal model variables during weight gain were calculated after 22.7 (WG1), 45.4 (WG2), 68.1 (WG3) and 90.8 
WG4) kg of gain. 
Variable 2 CFMM
 
(n = 9) 
TXMM 
(n = 9) 
WG1 
(n = 8) 
WG2 
(n = 9) 
WG3 
(n = 7) 
WG4 






SI, x 10 - 4 (mU/L) - 1 min – 1 5.37 ± 0.73 a 2.22 ± 0.73 b 3.28 ± 0.77 ab 3.69 ± 0.73 ab 3.87 ± 0.82 ab 2.66 ± 0.98 ab 
Sg, x10 - 2 min – 1 2.21 ± 0.30 a 2.93 ± 0.30 ab 2.67 ± 0.32 ab 3.18 ± 0.30 b 2.44 ± 0.34 ab 2.28 ± 0.40 ab 
AIRg, mU L - 1 min 467 ± 55 c 523 ± 55 bc 396 ± 59 c 431 ± 55 c 640 ± 63 ab 794 ± 75 a 
DI, x101 192± 27 ab 121 ± 27 bc 78 ± 28 c 113 ± 27 c 203 ± 30 a 211 ± 36 a 
Basal insulin, mU/L 14.16 ± 2.05 bc 6.19 ± 2.05 d 17.65 ± 2.17 ab 10.20 ± 2.05 cd 20.91 ± 2.17  a 21.35 ± 2.75 a 
Basal glucose, mg/dL 86.1 ± 8.8 75.2 ± 8.8 80.9 ± 9.3 81.6 ± 8.8 84.6 ± 9.3 79.4 ± 11.8 
 
a – d Means within rows with uncommon superscripts differ (P < 0.05). 
2 SI, insulin sensitivity; Sg, glucose effectiveness; AIRg, acute insulin response to glucose; DI, disposition index. 
 
















Figure 3.  Average serum leptin levels (ng/mL) in Thoroughbred geldings (n = 9) while fed commercial concentrate (wk 3) or 
treatment concentrate (wk 9) at maintenance and throughout weight gain (wk 10 to 41).  abc Least-squares means with uncommon 

















Figure 4.  Average serum cortisol (nmol/L) in Thoroughbred geldings (n = 9) while fed commercial concentrate (wk 3) or treatment 
concentrate (wk 9) at maintenance and throughout weight gain (wk 10 to 41).  Pooled SEM was 19.0 nmol/L.  abcd Least-squares 
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Figure 6.  Average whole-blood reduced (GSH; uM/L)  iz G ; / u o il f 
glutathione peroxidase antioxidant system o  a s , T u e r
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Glucose tolerance is altered in obese (Jeffcott et al., 1986; Freestone et al., 1992), 
lam
an tissue growth (Hornick et al., 
20
initic (Coffman and Colles, 1983) and obese-laminitic (Jeffcott et al., 1986) ponies.  
Research using direct measures of SI indicates that IR is a significant risk factor for 
pasture-associated laminitis in obese ponies (Treiber et al., 2006).  In the horse, SI is 
negatively correlated with BCS (Vick et al., 2007) and is lower in horses of high BCS (≥ 
7) than low BCS (≤ 6; Powell et al., 2002; Hoffman et al., 2003).  However, it is not 
known if SI deteriorates as BW is gained or if excessive adiposity must be maintained for 
a prolonged period of time before SI is affected. 
During the weight gain portion of the current study, the horses gained an average of 
0.35 kg/d and reached a maximum BCS ranging from 6.3 to 7.3.  The slight decline in 
ADG in January was most likely due to the provision of lower quality hay (hay # 2).  
Because a more rapid gain was observed during the first month (1.08 kg/d), the horses 
may have experienced an initial period of compensatory gain, a phenomenon common in 
feedlot cattle and finishing pigs where the provision of ad libitum feed following a period 
of energy restriction results in an initial period of rapid le
00).  In addition, during the current study, 32 kg were gained per one unit increase in 
BCS, an amount greater than that previously determined for mixed light-breed horses (16 
– 20 kg; Lawrence, 2000), possibly due to the leaner phenotype of the Thoroughbred.  
The reduction in SI between CFMM and TXMM likely reflects the continuing 
adaptation to the starches and sugars in the concentrates (Hoffman et al., 2003b), as both 




Previous studies in horses have shown that adaptive changes in glucose and insulin 
dynamics begin after 27 – 29 d (Sticker et al., 1995; Powell et al., 2002) and it is likely 
that the SI at CFMM, being only 21 d after the start of concentrate feeding, was not 
reflective of full starch and sugar adaptation.  Prior to the start of the study, horses had 
been maintained solely on mixed grass-alfalfa hay, which would be expected to be 
ass




ociated with a higher SI (Hoffman et al., 2003).  Full adaptation to the starches and 
sugars in the concentrates, including an increase in digestive enzyme production (Flores 
et al., 1988) and pancreatic insulin secretion (Kopp, 2003) most likely occurred between 
CFMM and TXMM.  Because the horses were able to maintain the SI seen at TXMM for 
the duration of weight gain, they were able to maintain an appropriate insulin secretion in 
response to the g
ich has been associated with IR in human obesity (Kopp, 2003).    
At the end of weight gain, SI was higher in the current study than that of obese horses 
(BCS ≥ 7, SI = 0.37 ± 0.27 x 10 - 4 (mU/L) - 1 min – 1; Hoffman et al., 2003) or laminitic 
ponies (BCS 6 - 8; SI = 0.39 ± 0.07 x 10 - 4 (mU/L) - 1 min – 1; Treiber et al., 2005b), 
indicating that the level of weight and BCS achieved in the current study was not likely to 
increase the risk of metabolic dysfunction.  While BCS has been correlated to SI (BCS 4 
– 9; r = -0.57, P < 0.001; Vick et al., 2007), no correlation between SI and BCS was 
found in the current study using horses between BCS 4.3 ± 0.1 and BCS 6.8 ± 0.1.  T
y be due to the narrow range of BCS scores in the current study or the utilization of 
different breeds, ages and gender by Vick et al. (2007).  Mares, such as those studied by 
Vick et al. (2007; 3 – 29 yr), especially mature mares, have been previously shown to 




(Fitzgerald and McManus, 2000; Lenhard et al., 2004) and as excessive adiposity is 
associated with reduced SI (Hoffman et al., 2003), this may explain the lack of 
congruency between studies. 
 The increases in AIRg and basal insulin between TXMM and WG4 may be due to 
increasing BW or in response to the treatment diet.  Similar results were noted for rats fed 
hig
response was no longer adequate to 
maintain glucose tolerance.  The effect of diet on AIRg in the horse is unclear, but higher 
AIRg was found in yearling horses fed a concentrate high in starch and sugar (Treiber et 
al., 2005b), although with a concomitant decrease in SI.  
Resistance to the satiety hormone leptin has been implicated in IR in various 
experimental models (Ceddia, 2005).  Leptin circulates in proportion to s.c. body fat 
levels in the horse (Buff et al., 2002) and has been shown in other models to promote a 
reduction in feed intake and increase in energy expenditure to compensate for excessive 
adiposity (Arch, 2005).  Leptin resistance refers to the maintenance of high circulating 
leptin levels in the presence of obesity and hyperinsulinemia (Halaas, 1997).  In the 
h glycemic diets, which had higher insulin secretion during an IVGTT than did rats 
fed low glycemic diets but no difference in SI (Pawlak et al., 2001).  The relationship 
between SI and AIRg is such that insulin secretion will be increased in order to prevent a 
decline in insulin action and ultimately maintain normal glucose tolerance (Araujo-Vilar 
et al., 1998).  In the present study, the increasing AIRg without a concurrent decrease in 
SI, reflected in the increasing DI, may be an early indication of pancreatic compensation 
for either weight gain or diet which, without intervention, may eventually lead to reduced 
SI (Hoffman et al., 2003).  Indeed, AIRg was reduced in obese horses with low SI 




current study, serum leptin levels increased by 60% between August and April, which 
was expected (Buff et al., 2002; Gentry et al., 2002; Kearns et al., 2005).  However, 
changes in leptin were not mirrored by changes in SI, indicating that the horses were not 
 to rule out pituitary adenoma in any 
ot unduly stressed or afflicted with a 
is in 
r dysfunction in the horse may 
t study 
rent study, the ratio of GSH:GSSG was chosen as an indication of the 
mage (Vincent and 
Taylor, 2006).  Because neither index of oxidative stress changed appreciably with 
leptin resistant as defined by Cartmill et al. (2003) in mares (BCS ≥ 7.5) fed native grass 
and ryegrass pasture.   
Cortisol was measured both to track the stress levels of the horses, as they were 
confined to stalls for the majority of the day, and
horse with abnormal glucose dynamics.  Cortisol levels were slightly lower than those 
reported by Van der Kolk et al. (2001) for normal horses and did not change over the 
course of the study, indicating that the horses were n
pituitary tumor.  
Oxidative stress is a risk factor for cardiovascular disease and type II diabetes in 
humans (Vincent and Taylor, 2006) and may be a risk factor underlying laminit
horses (Neville et al., 2004).  In humans, obesity-induced hyperglycemia is responsible 
for an increase in oxidative stress, resulting in endothelial dysfunction and poor vascular 
health (Vincent and Taylor, 2006).  The existence of simila
increase the risk of laminitis through damage to the vasculature within the hoof (Neville 
et al., 2004), however no evidence of oxidative stress was found in a recen
comparing previously laminitic ponies to non-laminitic ponies (Treiber et al., 2007).   
In the cur
activity of glutathione peroxidase, an enzyme responsible for ROS elimination, while 




weight gain in the present study, oxidative damage was likely obviated by the appropriate 
antioxidant systems.  Concentrations of GSH and GSSG were similar to those previously 
n the Thoroughbred gelding.  
e implications for horse owners.  However, changes in SI might have 
or if the horses had been assessed after 
 
Art, T. of oxidative stress in blood and 
reported in mature, healthy athletic horses (Art et al., 1999; Marlin et al., 2002; 
DeMoffarts et al., 2002) while LPO levels were lower than previously reported (Art et al., 
1999b; Williams et al., 2002). 
In conclusion, neither BW gain nor increased BCS affected SI within the limits of the 
current study, indicating that changes in adiposity between BCS 4.3 and 6.8 are not likely 
to be associated with an increased risk of metabolic disease i
As many horses fluctuate between the BCS range of the current experiment from season 
to season, the results of this study indicate that such changes are not likely to impair SI, 
which has positiv
been seen if weight gain had been continued such that horses reached a BCS > 7 
(Hoffman et al., 2003; Vick et al., 2007), 
maintaining BCS 7 for an extended period of time.  
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Insulin sensitivity (SI) in the horse is reduced in obesity, following the consumption of 




concentrates designed to differentially impact glucose and insulin dynamics, two 
experiments were carried out to assess the impact of controlled weight gain and exercise 
on SI so as to determine whether weight-gain associated changes in SI would be 
mo
the sixth wk, an additional 20 Mcal/d above maintenance was offered, 
resulting in an ADG of 0.35 kg/d over 41 wk (total gain 90.8 kg; final BW 609 ± 12 kg, 
BCS 7 ± 0.1).  To assess SI, frequently-sampled i.v. glucose tolerance tests were 
conducted prior to treatment initiation (wk 3), after the fourth wk of treatment 
concentrate feeding (wk 7), at the end of weight gain (wk 41) and following a 2 wk 
minimal exercise period.  During the minimal exercise period, exercise was reduced from 
twice-daily walking in a motorized horse exerciser to box stall confinement except during 
twice-daily stall cleaning.  The minimal model of glucose dynamics was used to estimate 
SI, glucose effectiveness and the acute insulin response to glucose (AIRg) from each 
glucose tolerance test.  At wk 3, no significant differences existed between treatment 
groups for any variable.  Within HF, SI and AIRg remained unchanged at all time points.  
Within HS, SI decreased at wk 7 (P = 0.01) and remained unchanged at wk 41.  The SI in 
HS was lower than HF at wk 7 (P = 0.004) and wk 41 (P = 0.07).  At wk 41, AIRg was 
higher in HS than HF (P = 0.01) and glucose effectiveness was reduced in both diets (P < 
0.05).  Following the minimal exercise period, SI decreased in HF (P = 0.03) but was 
dulated by dietary energy source or exercise restriction.  Fifteen mature Thoroughbred 
geldings (BW 519 ± 10 kg, BCS 4.3 ± 0.1) were fed hay and a commercial concentrate 
twice daily at maintenance for 3 wk followed by 6 wk acclimation to the treatment 
concentrates, one high in starch and sugar (HS; 57% non-structural carbohydrates, 4% 
fat; n = 9) and the other high in fat and fiber (HF, 20% non-structural carbohydrates, 17% 




unchanged in HS.  Overall, dietary energy source may be more influential than weight 
gain on SI in the mature Thoroughbred gelding between BCS 4 and 7.  The higher SI 
found in the horses consuming the high fat and fiber diet appears to be partially 
dependent on some level of physical activity. 
 




Insulin resistance (IR) in the equine is associated with breed (Jeffcott et al., 1986), 
obesity (Hoffman et al., 2003) and laminitis (Treiber et al., 2006).  During IR, tissue 
sensitivity to insulin is reduced and the normal level of insulin required to promote 
glucose uptake is no longer adequate (Wilcox, 2005).  Insulin sensitivity (SI) is also 
reduced following the consumption of high starch and sugar diets (Hoffman et al., 2003), 
which may be due to the increased glycemic response that occurs following ingestion 
(Stull and Rodiek, 1987).  An increasing number of obese horses are acquiring IR and 
laminitis (Johnson, 2002) and it is not known whether SI deteriorates as adiposity 
increases or as long periods of obesity are sustained.   
As dietary energy source impacts SI in both lean (Treiber et al., 2005) and obese 
(Hoffman et al., 2003) horses, the observation of IR in horses with pre-existing obesity 
may be due at least in part to diet.  Substitution of soluble carbohydrates with fat and 
fermentable fiber may improve SI in the non-obese horse (Treiber et al., 2005; Hoffman 
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exercise with the exception of being rem
rior to the morning feeding to estimate daily hay intake.  Due to 
the length of the study, three se
0900 and 1600 for 35 min at a speed of 1.2 m/s using an automated 6-horse exerciser 
(Priefert, Mt. Pleasant, TX) except during Exp. 2 when they were placed on a minimal 
exercise protocol.  During the 14 d minimal exercise period, the horses received no 
oved from their stalls twice daily during routine 
stall cleaning.  
  
Diets.  Prior to the start of the study, horses were maintained in the study facility and fed 
only mixed grass-alfalfa hay for a four wk period.  At the start of the study, horses were 
given three wk to acclimate to a diet of mixed grass-alfalfa hay and a texturized 
commercially available concentrate (CF; Legends 12, Southern States Cooperative, 
Richmond, VA; Table 1) at a level meeting their maintenance requirement for DE and 
providing vitamins and minerals at a level meeting or exceeding the minimum 
requirements for horses (NRC, 1989).   
Throughout the study, all horses had ad libitum access to water and iodized salt.  The 
hay was fed twice daily at 0800 and 1900 in floor-mounted wooden hay boxes and orts 
collected and weighed p
parate lots of hay were fed (Table 1) and three to five 
random core samples of hay taken from each lot were submitted to a commercial forage 
testing lab for nutrient analysis (Dairy One, Ithaca, NY).  Concentrate was offered in 
individual canvas nose bags (Derby Originals, North Canton, OH) and refusals weighed 
following each feeding to estimate concentrate intake, with horses given 45 min during 
which to consume the concentrate.  All diets were offered at a ratio of 60% hay to 40% 
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nd HF, h gh i  fat and f
It HF Lot 1 
(pre-study to wk 25) 
Lot 2 
(wk 26 to wk 29) 
em CF HS Lot 3 
(wk 30 to wk 41) 
P, % 03 a 9 ± 0.03 a 0.26 ± 0.03 0.17 ± 0.07 0.31 0
Ca, % ab 10 a 2 ± 0.10 b 0.92 ± 0.07 0.69 ± 0.19 0.86 0
Fat, % .1 17.2 ± 1.3 a 3.43 ± 0.14 2.40 ± 0.37 2.83 1
CP, % 0.6 10.1 ± 0.6 14.35 ± 0.54 11.00 ± 1.44 17.5 72
ADF, % 1.3 21.7 ± 1.3 a 31.40 ± 0.84 b 39.00 ± 2.21 c 35.05 1
NDF, % .3  6 50.7 .
NSC 2, 1.4 20.1 ± 1.4 a 17.47 ± 2.04 13.10 ± 5.39 10.3 .
DE, Mca 1 3 3.48 3 2.34 ± 0.04 1.98 ± 0.10 b 2.31 0
0.61 ± 0.04 
1.1  ± 0.02 
8.2 ± 0.4 
14.4 ± 0.3 ª 
10.0 ± 3 
20.0 ± 2 
53.0 ± 0.1 
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 bution of ingredients (Ha ris and Kronf
resulted in hay being essentially fed ad libitum. All dietary transitions were made over a 
7d period.  Grab samples of concentrate (n = 8) were submitted to a commercial 
laboratory (Dairy One, Ithaca, NY) for nutrient analysis.  
At wk 4, the horses were transitioned onto one of two treatment concentrates (Table 1) 
offered at a level meeting their maintenance DE requirement (NRC, 1989).  After six wk, 
the amount of DE offered was increased to 20 Mcal above maintenance per day to 
encourage weight gain.  The DE offered was recalculated weekly following the 
assesment of weight gain to account for the increasing maintenance requirement.  While 
hay lot two was being fed, the rate of weight gain began to decline and so a third 
concentrate feeding was added (at 1300), which offered an additional 7 Mcal DE.  
Refusals of hay and concentrate were recorded daily and a seven day period at the end of 
 
h and sugar concentrate (HS, n = 9) and high fat and fiber concentrate (HF, 
n =
nt method of determining DE in equine  
every month was averaged to estimate feed intake.  Data from one horse was excluded 
from the estimation of intake due to excessive urination on the refused hay.  Weight gain 
was terminated after 41 wk when the average initial BW had increased by 90.8 kg.  
Following the end of weight gain, horses continued on the same diets fed at maintenance 
through Exp. 2.   
The two treatment concentrates to which the horses were randomly assigned consisted 
of a high starc
 6), formulated to meet or exceed the minimum requirements for DE, vitamins and 
minerals for horses at maintenance (Table 2; NRC, 1989).  The diets were formulated to 
be isoenergetic (HF, 3.48 Mcal/kg; HS, 3.59 Mcal/kg) but the DE estimated by the 
commercial laboratory indicated a significant difference between the two diets (data not 




Table 2.  Ingredient composition of treatment concentrates, formulated to be either high 
in starch and sugar (HS) or high in fat and fiber (HF) fed from wk four to the end of 
weight gain (wk 41) 
Ingredient, % HS HF 
Corn 56.0 4.0 
Corn oil 0 14 
Distillers grains 7.0 10.0 
Soybean meal 5.0 10.0 




Oats 12.5 4.0 
Beet pulp 5.0 46.0 
Molasses 5.0 3.0 
Mixed hay 5.0 5.0 
Limestone 0.5 0.0 
Vitamin D 0.2 0.1 
Mineral premix 1 2.3 
itamin, mineral and amino acid premix 2 1.0 1.0 
Chelated mineral supplement  0.0 0.1 
  
1 Grass-plus Mineral, Buckeye Nutrition, Dalton, OH; Guaranteed analysis: CP, 8%; 
2%; Mg, 1.5%; Mn, 900 ppm; Fe, 1150 ppm; Cu, 550 ppm; Zn, 1300 ppm; Co, 15 ppm; 
1,760 IU/kg.  
2 Harvest Salt, Buckeye Nutrition, Dalton, OH; Guaranteed analysis: NaCl (minimum), 
ppm; I, 40 ppm; Se, 40 ppm. 
3 Zinpro 4 - plex, Zinpro Corporation, Eden Prairie, MN; Typical analys
lysine, 2.5 %; methionine, 1.3%; Ca (minimum) 19%; Ca (maximum) 22%; P, 6%; K, 
I, 15 ppm; Se, 9 ppm; vitamin A, 176,000 IU/kg; vitamin D-3, 17,600 IU/kg; vitamin E, 
 
93%; NaCl (maximum), 96%; Mn, 500 ppm; Cu, 2500 ppm; Zn, 5000 ppm; Co, 150 
 
is: Zn, 2.58%; 
Mn, 1.43%; Cu, 0.90%; Co, 0.18%; methionine, 8.21%; lysine, 3.80%; protein, 11.5%; 





At the end of weight gain, rump fat thickness was measured via ultrasound and percent 
ds is by using one of several equations (Harris, 1999) utilizing the chemical 
composition of the investigated feed.  However, these equations have been found to 
underestimate the DE available to the horse fed a diet high in fat and fiber.  This is 
because the calculated DE is thought to underestimate the energy contribution of added 
fat (e.g. corn oil, 9 kcal DE/g) and fermentable fiber (e.g. beet pulp, 2 kcal DE/g; Harris 
and Kronfeld, 2003).  The DE for the HS and HF concentrates in the current study was 
calculated from the ingredient composition of the diets (Table 2) using the 
recommendations of Harris and Kronfeld (2003) while the DE calculated by the 
commercial laboratory was used for the CF concentrate due to the proprietary nature of 
the commercial feed ingredients. 
 
Assessment of weight gain:  Horses were weighed every two wk on a livestock scale 
(Preifert, Mt. Pleasant, TX) beginning at wk 1.  BCS was assessed at wk 3, wk 7, wk 9 
and every four wk thereafter by two independent researchers using the Henneke BCS 
system (Henneke et al., 1983).  Each researcher assigned a numerical score (range 1 to 9 
with half-scores possible) to the six different body areas which were then averaged to 
calculate the BCS.  The final BCS was calculated by averaging the BCS scores from both 
researchers.   
body fat calculated by the equation of  Kane et al. (1987), % fat = 2.47 + 5.47 (rump 
fatcm).  Fat depth was measured 6 cm lateral from the midline at the center of the pelvic 
bone using b-mode ultrasound with a 15.24 cm linear transducer and frequency of 3.5 Hz 




Minimal exercise period.  Following  completion of Exp. 1, a 14 d minimal exercise 
period was initiated for all horses (Exp. 2).  Exercise was limited to removal of horses 
from stalls twice daily during routine stall cleaning.  Horses were restrained using cross-
es and immediately returned to their stall following completion of cleaning.  All other 
wk minimal exercise period (MINEX).  No 
ore than four horses were scheduled for an FSIGT on any given day.   
ti
procedures were conducted as for Exp. 1.  
  
FSIGT: Horses were subjected to frequently sampled intravenous glucose tolerance tests 
(FSIGT) previously validated in the horse (Hoffman et al., 2003).  During Exp. 1, 
FSIGTs were performed following the third wk of CF feeding at maintenance (CFMM), 
following the fourth wk of treatment concentrate feeding at maintenance (TXMM) and 
when the horses had reached an average weight gain of 90.8 kg (wk 41; ENDMM).  The 
third FSIGT from Exp. 1 (ENDMM) was used as the starting FSIGT in Exp. 2, with a 
final FSIGT carried out at the end of the 2 
m
The night before each FSIGT, horses were asceptically fitted with an indwelling 14 
guage jugular catheter with attached 5.5 mL total volume extension set, kept patent with 
12 mL of heparinized saline (0.75 mL heparin/1000 mL isotonic saline).  At 0600 on the 
day of the FSIGT, horses were fed their morning ration of hay only and had access to hay 
and water during the entire FSIGT.  No concentrate was provided to any horse during an 
FSIGT.  Provision of hay during the FSIGT (Hoffman et al., 2003; Treiber et al., 2005) is 
thought to reduce the effect of fasting on glucose dynamics (Forhead and Dobson, 1997), 




The morning of the FSIGT, horse BW was measured in order to accurately determine 
the level of glucose and insulin to be administered.  Glucose (50% dextrose solution, 
AmTech Group, Inc., St. Joseph, MO) was administered as an i.v. bolus of 300 mg/kg 
BW.  Insulin (HumulinR, Eli Lilly and Co., Indianapolis, IA) was administered as an i.v. 
bolus of 20 mIU/kg BW.  Prior to glucose administration, three blood samples were taken 
(0730, 0745 and 0759) for determination of basal glucose and insulin levels.  Intravenous 
glucose was administered over a 2 - 3 minute period beginning at 0800.  Thirty-five 
venous blood samples were taken at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 19, 22, 23, 24, 
25, 27, 30, 35, 40, 50, 60, 70, 80, 90, 100, 120, 150, 180, 210 and 240 minutes after 
glucose was administered.  Insulin dosing occurred 20 min after the glucose was 
administered.  For each sample, 20 mL of whole blood was immediately transferred into 
one of two glass specimen tubes containing either sodium fluoride/potassium oxalate 
(Vacutainer, Becton Dickenson, Franklin Lakes, NJ) or no additive (Fisher Scientific, 
Pittsburgh, PA).  Blood from the sodium fluoride/potassium oxalate tubes were 
immediately centrifuged at 4° C for 15 min at 2000 x g while blood from the additive-
free tubes was allowed to clot for 2 h at room temperature before being centrifuged at 4° 
C for 15 min at 2000 x g.  Serum and plasma were transferred to 1.5 mL microtubes and 
stored at -20° C until analysis.  
 
Analysis of Blood Hormones:  Serum insulin was measured in duplicate using RIA 
techniques (Coat-A-Count Insulin, Diagnostics Products Corporation, Los Angeles, CA) 
previously validated for use in the horse (Freestone et al., 1991).  The intraassay CV was 







colorimetric assay (Glucose C-2, Wako Chemicals, Richmond, VA), wherein samples 
were read at 505 nm on an absorbance microplate reader (Tecan Sunrise, Phenix 
Research Products, Hayward, CA).  The intraassay CV of triplicate s les was 5%. 
 
Minimal Model Analysis: Raw glucose and insulin data were m l y MinMod 
Millenium (Ver. 6.02, 2001) using equations previously validated in the horse (Hoffman 
et al., 2003).  Variables estimated included SI, insulin-independent glucose uptake 
(glucose effectiveness; Sg) and the acute insulin response to glucos  which is a 
reflection of post-hepatic insulin concentration derived from the fir
FSIGT.  The disposition index (DI), calculated from the product of SI and AIRg, is a 
reflection of pancreatic β-cell function, corrected for the degree of IR (B an, 1997).  
Data from six individual horse FSIGTs were excluded from the analysis due to poor 
parameter resolution (f_sd ≥ 0.5, 6.7%).      
 
Statistical Analysis.  All statistical analyses were performed using SAS statistical 
software (v. 9.1, Cary, N.C.).  Assumptions of normality and hom
were evaluated by examination of the residual plot and found to be t for all variables 
except SI and basal glucose, which were adjusted by base-10 logarithmic transformation 
for analysis.  All variables were analyzed by repeated measures m  el OVA 
using orthoganal contrasts for least-squares mean comparisons a linear 
changes over time.  The values for SI, Airg, Sg and basal insulin at CFMM were used as 
a covariate and for all ANOVA analyses, the appropriate correlation matrix for repeated 
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Average BW and BCS are presented in Figure 1.  No treatment group differences were 
found for BW (P = 0.93) or BCS (P = 0.08) so data were pooled for analysis.  Following 
the three wk adaptation to the CF concentrate, average BW was 524 ± 12 kg (range 466 
to 596 kg) and BCS was 4.4 ± 0.1 (range 3.7 –to 5.1).  Horses maintained BW and BCS 
through the start of weight gain (wk 9; BW, 519 ± 15 kg, range 473 – 590 kg, P = 0.57; 
BCS, 4.3 ± 0.1, range 4.0 – 4.6, P = 0.77).  Following the initiation of weight gain, mean 
BW and BCS increased (P < 0.0001) to wk 41.  Final average BW was 608 ± 12 kg 
(range 539 to 702 kg) and average BCS was 6.9 ± 0.1 (range 6.3 to 7.5).  Regression of 
BCS on BW (data not shown) indicated that a one unit increase in BCS required a gain of 
32 kg (r  = 0.32, P < 0.0001).  Regression of BCS on time (data not shown) indicated 
that it required 80 d to gain one BCS (r  = 0.89, P < 0.0001).  Ultrasound-derived rump 
model effects included day, treatment and treatment*day and the random effect was horse 
(within treatment).  Data are presented as least-squares m
ean comparisons when appropriate.  Although the data 
for log-normal variables are presented as least-squares means ± SEM, significant 



















Figure 1.  Changes in average BW and BCS of Thoroughbred geldings (n = 15) while fed commercial concentrate (wk 3) or treatment 
concentrate (wk 9) at maintenance and throughout weight gain (wk 10 – 41).  Pooled SEM was 15 kg for BW and 0.1 for BCS.  abcdefg 
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after the fourth week of treatment concentrate feeding at maintenance (TXMM) and following 90.8 kg of BW gain 
(ENDMM) 
  HS    HF  
Table 3.  Least-squares means ± SEM for minimal model variables during weight gain in Thoroughbred geldings fed a diet high in 




(n = 9) 
M M T ENDMM 
(n = 6) 
SI, x10 - 4 (mU/L) a b ab  4.97 ± 0.70 a 
Sg, x10 - 2 min 2.27 ± 0.30 cd 0 ab  d  2  3.5 2.04 ± 0.46 cd 
AIRg, mU L - 4 ± 57 ab 7 a a  37 291 ± 64 b 
DI, x101 192 ± 34 34 4  15 109 ± 32 
Basal insulin, 93 ± 1.41 1 a 1  6. 14.02 ± 2.62 
Basal glucose 1 ± 8.3 3   6 84.2 ± 9.8 
TXM
(n = 9) 
ENDM
(n = 9) 
 CFMM 
(n = 6) 
XMM 
(n = 4) 
 - 1 min - 1 5.13 ± 0.74 2.09 ± 0.74 2.63 ± 0.74 4.48 ± 0.70 a 5.07 ± 0.85 a 
 - 1 2.99 ± 0.3 2.01 ± 0.30 .47 ± 0.46 abc 0 ± 0.55 ab 
1 min 42 479 ± 5 549 ± 57 400 ± 64 ab 5 ± 78 ab 
121 ± 152 ± 3 141 ± 32 3 ± 39 
mUL 13. 5.96 ± 1.4 14.18 ± 1.4 13.92 ± 2.62 61 ± 3.12 b 
, mg/dL 86. 75.2 ± 8. 85.0 ± 8.3 90.3 ± 9.8 8.9 ± 11.7 
 
2 
1 Legends 12, Southern States Cooperative, Richmond, VA. 
SI, insulin sensitivity; Sg, glucose effectiveness; AIRg, acute insulin response to glucose; DI, disposition index. 




k 41) and the end of the minimal exercise period 





Obesity in the Thoroughbred has been reported in the literature (Hoffman et al., 2003), 
and while not as common as obesity in the pony, Morgan, Spanish Mustang or European 
Warmblood (Johnson, 2002), it may be similarly effective in inducing a state of 
metabolic dysfunction.  The reduction in SI that accompanies increased adiposity in 
differences for basal insulin were found at TXMM (P = 0.64) or ENDMM (P = 0.96).  




Between the end of weight gain (w
ent or time differences were found for BCS (P = 0.53; P = 0.79) but a 
significant time effect (P = 0.001) and treatment by time interaction (P = 0.01) were 
found within BW.  Evaluation of the simple effect mean comparisons revealed a 
significant increase in BW within HF, from 602 ± 24 kg at wk 41 to 611 ± 24 kg at wk 43 
(P = 0.002).  Average BW at wk 41 within HS (616 ± 19kg) was not different from BW 
at wk 43 (617 ± 19 kg; P = 0.90).  Data for minimal model variables are presented in 
Table 4.  At MINEX, SI had decreased (P = 0.07) in HF but was unchanged in HS.  No 
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ponies is a significant risk factor for the development of pasture-associated laminitis 
(Treiber et al., 2006).  In the horse, SI is negatively correlated with BCS (Vick et al., 
2007) 2007) and is lower in horses of high BCS (≥7) than low BCS (≤ 6; Powell et 2002; 
Ho
ge of 32 kg gain per unit of BCS.  Such breed-specific 
dif
HS group lower than HF at TXMM and ENDMM.  However, SI in the current study 
ffman et al., 2003).  However, the SI threshold at which the risk of metabolic disease 
increases is unknown and may be related to an achieved level of body fat or the length of 
sustained obesity or both.   
Weight gain in the Thoroughbred, as measured in this study, appears to occur at a 
slower rate than that of other breeds and types of horse (Heusner et al., 1993; Pagan et al., 
1987).  Additionally, the Thoroughbred seems to require a greater BW gain per unit of 
BCS as compared to mixed light-breed horses (16 – 20 kg; Lawrence, 2000), as results of 
the current study indicate an avera
ferences suggest that recommendations for weight gain in the mature horse should be 
specialized beyond the basic generalization of ‘light breed,’ ‘pony’ or ‘draft’ and that 
research studying the effects of BW or BCS on physiological parameters utilize a single 
breed, gender and maturity of horse.  
Diets high in starches and sugars are associated with changes in glucose and insulin 
dynamics, including post-prandial glucose and insulin responses that are greater than 
those from forages alone or fat-supplemented rations (Stull and Rodiek, 1987; Pagan et 
al., 1999; Williams et al., 2001; Ropp et al., 2003).  Additionally, SI is reduced in horses 
fed high starch and sugar concentrates as compared to concentrates where the energy 
from non-structural carbohydrates is replaced by fat and fermentable fiber (Treiber et al., 




(BCS 4.3 – 7.0) was not reduced to levels previously found in obese horses (BCS ≥ 7, SI 
= 0.37 ± 0.27 x 10 - 4 (mU/L) - 1 min – 1; Hoffman et al., 2003) or laminitic ponies (BCS 6 - 
; SI = 0.39 ± 0.07 x 10 - 4 (mU/L) - 1 min – 1; Treiber et al., 2005b). 
The HS concentrate was formulated to be very similar to the CF concentrate in the 
hes and sugars provided and would therefore be expected to have the 
me effect on SI.  It was assumed that adaptation to the starches and sugars would have 
oc





curred in both groups during the 3 wk prior to CFMM, but it is likely that a longer 
period of time was required (Sticker et al., 1995; Powell et al., 2002).  The SI for HS at 
TXMM likely represents sufficient adaptation to the starches and sugars, which was not 
achieved in HF due to the dietary switch.  Prior to the start of the study, the horses had 
been fed a diet consisting solely of mixed grass-alfalfa hay and the lack of change in SI in 
HF may indicate that the horses were able to maintain an SI hypothesi
ilar to that of hay alone.  Because both groups were able to maintain SI at the TXMM 
level for the duration of the study, they appear to have developed long-term tolerance to 
the diets (Hoffman et al., 2003b).  
The lack of statistical significance between dietary treatments may be due to the 
higher variability and lower repeatability of the minimal model as compared to other 
experimental paradigms, such as the euglycemic-hyperinsulinemic clamp (Frank et al., 
2005; Pratt et al., 2005).  Additionally, although all horses were tattooed Thoroughbreds, 
differences in phenotype within the pool of study subjects may have contributed to the 
variation within treatment groups.  However, the consistency of SI measured in HF and 
its tendency to remain higher than HS is a reflection of the physiological response to the 




to dampen the glycemic response of feeds high in non-structural carbohydrates in the 
horse (Stull and Rodiek, 1987; Lindberg and Palmgren-Karlsson, 2001) as well as 
improve SI (Treiber et al., 2005). 
  The higher AIRg in HS at ENDMM may be in response to the lower SI and may be 
reflective of the ability of the horse to adapt to chronic feeding of diets high in starch and 
sugar (Treiber et al., 2005).  Normal glucose tolerance can be maintained even with 
red
nig et al., 2006) 
bu
in Sg may have been in response to the higher SI, as lower SI in human 
uced SI through a compensatory increase in insulin secretion, reflected in AIRg 
(Araujo-Vilar et al., 1998).  However, previous research using obese horses (BCS ≥ 7; 
Hoffman et al., 2003) found that AIRg was reduced in obesity, indicating that the 
compensatory insulin response may have no longer been adequate to maintain glucose 
tolerance (Hoffman et al., 2003). 
Diet does not appear to influence Sg in the horse (Hoffman et al., 2003; Treiber et al., 
2005).  The reduction in Sg in both treatment groups between TXMM and ENDMM may 
reflect weight gain, although obese geldings (BCS ≥ 7; Hoffman et al., 2003) had a 
higher Sg than did moderately- and non-obese geldings (BCS 5 – 5.9 and BCS 6 – 6.9, 
respectively).  However, Sg was found to be reduced in obese cats (Hoe
t differentially increased or decreased in obese humans depending on their state of 
glucose tolerance (Taniguchi et al., 1994).  In the current study, the reduction in Sg at 
ENDMM in the HS group may have been in response to the increased AIRg, as a 
decrease in insulin-independent glucose uptake may be expected to offset an increase in 






lland et al. (1996) in horses stalled overnight and allowed 
acc
jects with obesity or Type II diabetes is accompanied by a compensatory increase in 





Although it is known that forced exercise improves SI in the horse (Freestone et al., 
1992b; Powell et al., 2002), many horses kept primarily as companion animals receive 
little forced exercise.  These animals may be at a greater risk for obesity if their caloric 
intake is not reduced and as such may be at a greater risk for IR and metabolic disease.  
However, the degree to which SI in the obese horse or the horse fed a concentrate high in 
starch and sugar is further impaired by a sedentary existence is unknown. 
During the current study, the horses were exercised at a walk for 35 min twice daily at 
a speed of 1.2 m/s, which is equivalent to 5.12 km of walking per day, a distance within 
the range estimated by Ho
ess to paddocks during the day (4 – 10 km/d).  Following the 2 wk minimal exercise 
period during which the horses were kept in stalls except during routine stall cleaning, SI 
remained unchanged in the HS horses, indicating that the lower level of SI achieved 
following adaptation to the treatment concentrate was not further impacted by the level of 
exercise.  However, SI was reduced by 55% in the HF horses, indicating that the 
protective effect of a fat and fiber diet on SI is at least partially dependent on the ability 
of the animal to carry out some amount of regular activity.  In addition, the HF horses 




was not seen in the HS group (+ 1 kg), despite the fact that both groups were being fed at 
maintenance levels.  Because changes in SI have been observed at BCS ≥7 (Hoffman et 
al., 2003), there may be a point in the continuum of BW gain where SI may be reduced 
regardless of diet.  The reduction in SI within HF may indicate that the protective effect 
of diet may have ceased once the horses had reached a theoretical upper limit of ‘safe’ 
BW gain.   
Exercise has been previously shown to differentially impact SI in horses fed a diet 
high in starch and sugar versus a diet high in fat and fiber (Treiber, 2006).  In endurance-
trained Arabian geldings, SI measured during a standard exercise test consisting of 
trotting at 57% of the lactate threshold was increased to a greater extent in high fat and 
fiber-fed horses (12-fold) versus high starch and sugar-fed horses (7-fold).  It was 
hypothesized that the high fat and fiber-fed horses were better able to adapt to the energy 
demands of exercise by increasing their insulin-sensitive glucose uptake (Treiber, 2006).  
An increased ‘metabolic flexibility (Treiber, 2006)’ in high fat and fiber-fed horses, while 
beneficial when exercise is increased to the level of an endurance-trained athlete, may be 
responsible for the reduction in SI in the HF group in the current study.  
While SI was reduced in the HF group, neither AIRg nor Sg were affected, perhaps 
because SI may not have been reduced to a level requiring compensation by the primary 
mechanisms involved in glucose uptake.  As in Exp. 1, SI was not reduced to the level of 
obese horses (BCS ≥ 7; Hoffman et al., 2003), overweight ponies or laminitic ponies 
(BCS 6 – 8; Treiber et al., 2005b), indicating that the risk of metabolic disease was most 




Results of this study provide evidence that SI in the Thoroughbred may be more 
affected by dietary energy source and exercise than BW gain to a BCS < 7.  Diets high in 
fat and fiber are recommended for horses and ponies at risk for metabolic disease, such as 
y not be detrimental to the healthy horse.  While the HS diet was 
er et al., 2005b).  
d 7.0.  Additionally, while exercise 
 
fore, horses not subjected to regular forced exercise may not be at increased risk for 
SI than that of Thoroughbred geldings fed a concentrate 
this may indicate that the 
t the end of the minimal exercise period, it did 
not drop below that observed in laminitic ponies.  This may indicate that the sedentary 
those with chronic laminitis or equine Cushing’s disease (Kronfeld and Harris, 2003).  
However, diets high in starch and sugar with NSC levels comparable to those in the 
current study ma
associated with a reduction in SI in the current study, SI did not reach the level 
previously associated with an increased risk of laminitis in ponies (Treib
This indicates that such diets may not increase the risk of metabolic disease in the healthy 
horse when it gains weight between BCS 4.0 an
restriction was associated with reduced SI in the HF group, the final SI value was above 
that previously associated with a risk of laminitis in the pony (Treiber et al., 2005b). 
There
metabolic disorder when fed concentrates high in starch and sugar as long as they are 
maintained at a BCS < 7.0. 
 In conclusion, feeding a concentrate high in fat and fiber to Thoroughbred geldings 
was associated with a higher 
high in starch and sugar.  A novel finding of the current research is the divergent effect of 
exercise restriction on SI in the two treatment groups.  While 
effects of the HF diet on SI may be partially dependent on the animals carrying out some 
level of exercise, the contribution of weight gain cannot be ignored.  However, even 




horse, if gaining weight between BCS 4.0 and 7.0, may not be at an increased risk for 
metabolic disease regardless of dietary energy source fed.   However, horses which 
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GENERAL SUMMARY AND CONCLUSIONS 
 change in SI that would be consistent with declining glucose 
tolerance (Hoffman et al., 2003)
 
th BW gain in either study, SI was 
gnificantly lower in those horses fed the high starch and sugar concentrate following 
acclimation to the diet and remained numerically lower through the end of weight gain.  
However, this level of SI was not associated with metabolic disease, although one horse 
on the HS diet did show anecdotal evidence of polydypsia, polyurea and foot soreness.  
 
Body weight gain in the Thoroughbred gelding fed a diet high in starches and sugars 
was not associated with a
.  However, when compared to a cohort of horses fed a 
diet high in fat in fiber, a divergent effect of dietary energy source on SI can be observed. 
The substitution of fats and fermentable fibers for starches and sugars in equine diets has 
been recommended to reduce the risk of developing or exacerbating colic, laminitis, 
polysaccharide storage myopathy and other conditions, as well as spare glycogen during 
athletic activities and stimulate calm, quiet behavior in stall-kept horses (Kronfeld and 
Harris, 2003).  More recently, evidence has emerged that diets high in fat and fiber can 
increase SI in both weanling and mature Thoroughbreds (Hoffman et al., 2003; Treiber et 
al., 2005).  Coupled with the observation that Thoroughbreds of BCS ≥ 7 have reduced SI 
(Hoffman et al., 2003) and that IR is an underlying and perhaps predisposing factor for 
laminitis in ponies (Treiber et al., 2006), we hypothesized that the provision of a high fat 
and fiber diet to Thoroughbreds gaining weight would attenuate any negative weight 
gain-associated fluctuations in SI and thus reduce the risk of metabolic disease.    




While no standard values for SI in the healthy and non-healthy Thoroughbred gelding 
exist, the SI values in the cu  6.5 times higher than those 
ported by Hoffman and colleagues (2003) in Thoroughbred geldings of BCS ≥ 7, likely 
dicating that the risk of metabolic disease was lower in the current research.   
Because no appreciable weight-gain associated effect on glucose and insulin dynamics 
ere found in this study, the observed changes in AIRg and Sg are most likely 
ttributable to dietary energy source.  Insulin resistance in humans is often accompanied 
y a compensatory, although inadequate, increase in insulin secretion, (Aurajo-Vilar et 
l., 1988).  In the current study, the lower SI associated with the HS diet may have been 
ountered by the increase in AIRg for the purpose of maintaining glucose tolerance.  
owever, the progression of IR often culminates in inadequate insulin secretion and 
lucose intolerance, previously observed in the Thoroughbred of BCS ≥ 7 (Hoffman et 
l., 2003).   
The unique response of the treatment groups to cessation of exercise underscores the 
eed for some level of spontaneous, if not forced, daily exercise in all horses.  While 
minitis was not observed in this study, the fact that SI declined in the HF group during 
e minimal exercise period indicates that the risk of laminitis may be increased in 
dentary horses.  Perhaps a further decline in SI would have been observed in the HS 
orses if the minimal exercise period had been lengthened.  The divergent impact of 
xercise on SI in the two treatment groups may be reflective of the ability of the horse to 
tilize stored glucose and fatty acids more efficiently when adapted to the HF diet.   
During exercise, a high SI is necessary for adequate glucose uptake into muscles while 
low insulin levels are required to facilitate lipolysis.  The higher basal insulin and AIRg 




















in high starch and sugar fed horses may negatively impact the animals’ ability to utilize 
ored adipose tissue for energy (Treiber, 2006).  The increased flexibility of the fat and 
ber-fed horse to choose the appropriate substrate for exercise, be it glucose for high 
tensity or NEFA for low intensity, may also make the animal more sensitive to a 
duction in exercise.      
Research in humans finds that IR is a risk factor for metabolic disease in obese, 
enetically predisposed individuals following exposure to a dietary trigger such as a diet 
igh in starch and sugar (Kopp, 2003).  However, the development of laminitis as 
pposed to diabetes in the horse indicates that the horse responds to excessive adiposity 
nd highly insulinogenic diets in a unique way which warrants further research.  We and 
thers (Hoffman et al., 2003; Treiber et al., 2005) have found that equine SI can be 
ffected by BW, BCS and diet and it is likely that the horse will respond similarly to the 
ony, albeit with a slower progression.  In the horse, however, the rapidity at which SI 
eteriorates to a level where the laminitis risk is increased is unknown and is most likely 
lated to the length of sustained obesity as well as the individual animal’s ability to 
ompensate for changing glucose tolerance.  Because the likelihood of an individual 
orse developing IR and laminitis following the attainment of obesity cannot yet be 
redicted, light breed horses should be maintained at a moderate BCS (4 – 6) for the 
























































































Figure I. (Chapter II, III).  Raw glucose and insulin responses of Thoroughbred geldings 





































































Figure 2. (Chapter II, III).  Raw glucose and insulin responses to a frequently sampled 


















































Figure 3 h r II).  Raw plasma glucose responses in Thoroughbred geldings to a frequently sampled i.v. glucose tolerance test 
in, WG1, WG2, WG3 and WG4. 
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Figure 4. h  II).  Raw serum insulin responses in Thoroughbred geldings to a frequently sampled i.v. glucose tolerance test 



















































Figure 5. (Chapter III).  Raw glucose and insulin responses in Thoroughbred geldings to 























































































Figure 6. (Chapter III).  Raw glucose and insulin responses in Thoroughbred geldings to 
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